DECOR Information for Project: epSOS (epsos-)

Value sets

 RoleClassAssociative 2011‑07‑26

Value Set Name Value Set Id Version / effective date Status
RoleClassAssociative 2.16.840.1.113883.1.11.19313 DEFN=UV=VO=1099-20110726 - 2011‑07‑26 Final
Source Code System:
  • 2.16.840.1.113883.5.110 RoleClass
Level/ Type Code Display Name Code System Description
1-A  _RoleClassMutualRelationship RoleClassMutualRelationship RoleClass
2-A   _RoleClassRelationshipFormal RoleClassRelationshipFormal RoleClass
3-L    AFFL affiliate RoleClass
3-S    AGNT agent RoleClass
4-S     ASSIGNED assigned entity RoleClass
5-L      COMPAR commissioning party RoleClass
5-L      SGNOFF signing authority or officer RoleClass
4-S     CON contact RoleClass
5-L      ECON emergency contact RoleClass
5-L      NOK next of kin RoleClass
4-L     GUARD guardian RoleClass
3-L    CIT citizen RoleClass
3-S    COVPTY covered party RoleClass
4-L     CLAIM claimant RoleClass
4-S     NAMED named insured RoleClass
5-L      DEPEN dependent RoleClass
5-L      INDIV individual RoleClass
5-L      SUBSCR subscriber RoleClass
4-L     PROG program eligible RoleClass
3-L    CRINV clinical research investigator RoleClass
3-L    CRSPNSR clinical research sponsor RoleClass
3-S    EMP employee RoleClass
4-L     MIL military person RoleClass
3-L    GUAR guarantor GuarantorRole RoleClass
3-S    INVSBJ Investigation Subject RoleClass
4-L     CASEBJ Case Subject RoleClass
4-L     RESBJ research subject RoleClass
3-S    LIC licensed entity RoleClass
4-L     NOT notary public RoleClass
4-L     PROV healthcare provider RoleClass
3-L    PAT patient RoleClass
3-L    PAYEE payee RoleClass
3-L    PAYOR invoice payor RoleClass
3-L    POLHOLD policy holder RoleClass
3-L    QUAL qualified entity RoleClass
3-L    SPNSR coverage sponsor RoleClass
3-L    STD student RoleClass
3-L    UNDWRT underwriter RoleClass
2-L   CAREGIVER caregiver RoleClass
2-L   PRS personal relationship RoleClass
1-A  _RoleClassPassive RoleClassPassive RoleClass
2-L   ACCESS access RoleClass
2-S   ADJY adjacency RoleClass
3-S    CONC connection RoleClass
4-L     BOND molecular bond RoleClass
4-L     CONY continuity RoleClass
2-L   ADMM Administerable Material RoleClass
2-L   BIRTHPL birthplace RoleClass
2-L   DEATHPLC place of death RoleClass
2-S   DST distributed material RoleClass
3-L    RET retailed material RoleClass
2-L   EXPR exposed entity RoleClass
2-L   HLD held entity RoleClass
2-L   HLTHCHRT health chart RoleClass
2-L   IDENT identified entity RoleClass
2-S   MANU manufactured product RoleClass
3-L    THER therapeutic agent RoleClass
2-L   MNT maintained entity RoleClass
2-L   OWN owned entity RoleClass
2-L   RGPR regulated product RoleClass
2-S   SDLOC service delivery location RoleClass
3-L    DSDLOC dedicated service delivery location health care facility RoleClass
3-L    ISDLOC incidental service delivery location RoleClass
2-L   TERR territory of authority RoleClass
2-L   USED used entity RoleClass
2-L   WRTE warranted product RoleClass
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 

 URLScheme 2011‑07‑26

Value Set Name Value Set Id Version / effective date Status
URLScheme 2.16.840.1.113883.1.11.14866 DEFN=UV=VO=1099-20110726 - 2011‑07‑26 Final
Source Code System:
  • 2.16.840.1.113883.5.143 URLScheme
  • 2.16.840.1.113883.5.1060
Level/ Type Code Display Name Code System Description
0-L cid Content ID URLScheme
0-L file File URLScheme
0-L ftp FTP URLScheme
0-L hl7-att HL7 Attachment URLScheme
0-L http HTTP URLScheme
0-L mailto Mailto URLScheme
0-L mllp MLLP URLScheme
0-L nfs NFS URLScheme
0-L tel Telephone URLScheme
0-L telnet Telnet URLScheme
0-L cid cid 2.16.840.1.113883.5.1060
0-L hl7-att HL7 Attachment URLScheme
0-L mailto Mailto URLScheme
0-L tel Telephone URLScheme
0-L tel Telephone URLScheme
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 

 epSOSActiveIngredient 2013‑06‑03
The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies an...

Description
The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.
Value Set Name Value Set Id Version / effective date Status
epSOSActiveIngredient 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 January 2010 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.73 WHO ATC
Level/ Type Code Display Name Code System Description
0-L A ALIMENTARY TRACT AND METABOLISM WHO ATC
0-L A01 STOMATOLOGICAL PREPARATIONS WHO ATC
0-L A01A STOMATOLOGICAL PREPARATIONS WHO ATC
0-L A01AA Caries prophylactic agents WHO ATC
0-L A01AA01 sodium fluoride WHO ATC
0-L A01AA02 sodium monofluorophosphate WHO ATC
0-L A01AA03 olaflur WHO ATC
0-L A01AA04 stannous fluoride WHO ATC
0-L A01AA30 combinations WHO ATC
0-L A01AA51 sodium fluoride, combinations WHO ATC
0-L A01AB Antiinfectives and antiseptics for local oral treatment WHO ATC
0-L A01AB02 hydrogen peroxide WHO ATC
0-L A01AB03 chlorhexidine WHO ATC
0-L A01AB04 amphotericin B WHO ATC
0-L A01AB05 polynoxylin WHO ATC
0-L A01AB06 domiphen WHO ATC
0-L A01AB07 oxyquinoline WHO ATC
0-L A01AB08 neomycin WHO ATC
0-L A01AB09 miconazole WHO ATC
0-L A01AB10 natamycin WHO ATC
0-L A01AB11 various WHO ATC
0-L A01AB12 hexetidine WHO ATC
0-L A01AB13 tetracycline WHO ATC
0-L A01AB14 benzoxonium chloride WHO ATC
0-L A01AB15 tibezonium iodide WHO ATC
0-L A01AB16 mepartricin WHO ATC
0-L A01AB17 metronidazole WHO ATC
0-L A01AB18 clotrimazole WHO ATC
0-L A01AB19 sodium perborate WHO ATC
0-L A01AB21 chlortetracycline WHO ATC
0-L A01AB22 doxycycline WHO ATC
0-L A01AB23 minocycline WHO ATC
0-L A01AC Corticosteroids for local oral treatment WHO ATC
0-L A01AC01 triamcinolone WHO ATC
0-L A01AC02 dexamethasone WHO ATC
0-L A01AC03 hydrocortisone WHO ATC
0-L A01AC54 prednisolone, combinations WHO ATC
0-L A01AD Other agents for local oral treatment WHO ATC
0-L A01AD01 epinephrine WHO ATC
0-L A01AD02 benzydamine WHO ATC
0-L A01AD05 acetylsalicylic acid WHO ATC
0-L A01AD06 adrenalone WHO ATC
0-L A01AD07 amlexanox WHO ATC
0-L A01AD08 becaplermin WHO ATC
0-L A01AD11 various WHO ATC
0-L A02 DRUGS FOR ACID RELATED DISORDERS WHO ATC
0-L A02A ANTACIDS WHO ATC
0-L A02AA Magnesium compounds WHO ATC
0-L A02AA01 magnesium carbonate WHO ATC
0-L A02AA02 magnesium oxide WHO ATC
0-L A02AA03 magnesium peroxide WHO ATC
0-L A02AA04 magnesium hydroxide WHO ATC
0-L A02AA05 magnesium silicate WHO ATC
0-L A02AA10 combinations WHO ATC
0-L A02AB Aluminium compounds WHO ATC
0-L A02AB01 aluminium hydroxide WHO ATC
0-L A02AB02 algeldrate WHO ATC
0-L A02AB03 aluminium phosphate WHO ATC
0-L A02AB04 dihydroxialumini sodium carbonate WHO ATC
0-L A02AB05 aluminium acetoacetate WHO ATC
0-L A02AB06 aloglutamol WHO ATC
0-L A02AB07 aluminium glycinate WHO ATC
0-L A02AB10 combinations WHO ATC
0-L A02AC Calcium compounds WHO ATC
0-L A02AC01 calcium carbonate WHO ATC
0-L A02AC02 calcium silicate WHO ATC
0-L A02AC10 combinations WHO ATC
0-L A02AD Combinations and complexes of aluminium, calcium and magnesium compounds WHO ATC
0-L A02AD01 ordinary salt combinations WHO ATC
0-L A02AD02 magaldrate WHO ATC
0-L A02AD03 almagate WHO ATC
0-L A02AD04 hydrotalcite WHO ATC
0-L A02AD05 almasilate WHO ATC
0-L A02AF Antacids with antiflatulents WHO ATC
0-L A02AF01 magaldrate and antiflatulents WHO ATC
0-L A02AF02 ordinary salt combinations and antiflatulents WHO ATC
0-L A02AG Antacids with antispasmodics WHO ATC
0-L A02AH Antacids with sodium bicarbonate WHO ATC
0-L A02AX Antacids, other combinations WHO ATC
0-L A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) WHO ATC
0-L A02BA H2-receptor antagonists WHO ATC
0-L A02BA01 cimetidine WHO ATC
0-L A02BA02 ranitidine WHO ATC
0-L A02BA03 famotidine WHO ATC
0-L A02BA04 nizatidine WHO ATC
0-L A02BA05 niperotidine WHO ATC
0-L A02BA06 roxatidine WHO ATC
0-L A02BA07 ranitidine bismuth citrate WHO ATC
0-L A02BA08 lafutidine WHO ATC
0-L A02BA51 cimetidine, combinations WHO ATC
0-L A02BA53 famotidine, combinations WHO ATC
0-L A02BB Prostaglandins WHO ATC
0-L A02BB01 misoprostol WHO ATC
0-L A02BB02 enprostil WHO ATC
0-L A02BC Proton pump inhibitors WHO ATC
0-L A02BC01 omeprazole WHO ATC
0-L A02BC02 pantoprazole WHO ATC
0-L A02BC03 lansoprazole WHO ATC
0-L A02BC04 rabeprazole WHO ATC
0-L A02BC05 esomeprazole WHO ATC
0-L A02BD Combinations for eradication of Helicobacter pylori WHO ATC
0-L A02BD01 omeprazole, amoxicillin and metronidazole WHO ATC
0-L A02BD02 lansoprazole, tetracycline and metronidazole WHO ATC
0-L A02BD03 lansoprazole, amoxicillin and metronidazole WHO ATC
0-L A02BD04 pantoprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD05 omeprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD06 esomeprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD07 lansoprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) WHO ATC
0-L A02BX01 carbenoxolone WHO ATC
0-L A02BX02 sucralfate WHO ATC
0-L A02BX03 pirenzepine WHO ATC
0-L A02BX04 methiosulfonium chloride WHO ATC
0-L A02BX05 bismuth subcitrate WHO ATC
0-L A02BX06 proglumide WHO ATC
0-L A02BX07 gefarnate WHO ATC
0-L A02BX08 sulglicotide WHO ATC
0-L A02BX09 acetoxolone WHO ATC
0-L A02BX10 zolimidine WHO ATC
0-L A02BX11 troxipide WHO ATC
0-L A02BX12 bismuth subnitrate WHO ATC
0-L A02BX13 alginic acid WHO ATC
0-L A02BX51 carbenoxolone, combinations excl. psycholeptics WHO ATC
0-L A02BX71 carbenoxolone, combinations with psycholeptics WHO ATC
0-L A02BX77 gefarnate, combinations with psycholeptics WHO ATC
0-L A02X OTHER DRUGS FOR ACID RELATED DISORDERS WHO ATC
0-L A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS WHO ATC
0-L A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS WHO ATC
0-L A03AA Synthetic anticholinergics, esters with tertiary amino group WHO ATC
0-L A03AA01 oxyphencyclimine WHO ATC
0-L A03AA03 camylofin WHO ATC
0-L A03AA04 mebeverine WHO ATC
0-L A03AA05 trimebutine WHO ATC
0-L A03AA06 rociverine WHO ATC
0-L A03AA07 dicycloverine WHO ATC
0-L A03AA08 dihexyverine WHO ATC
0-L A03AA09 difemerine WHO ATC
0-L A03AA30 piperidolate WHO ATC
0-L A03AB Synthetic anticholinergics, quaternary ammonium compounds WHO ATC
0-L A03AB01 benzilone WHO ATC
0-L A03AB02 glycopyrronium WHO ATC
0-L A03AB03 oxyphenonium WHO ATC
0-L A03AB04 penthienate WHO ATC
0-L A03AB05 propantheline WHO ATC
0-L A03AB06 otilonium bromide WHO ATC
0-L A03AB07 methantheline WHO ATC
0-L A03AB08 tridihexethyl WHO ATC
0-L A03AB09 isopropamide WHO ATC
0-L A03AB10 hexocyclium WHO ATC
0-L A03AB11 poldine WHO ATC
0-L A03AB12 mepenzolate WHO ATC
0-L A03AB13 bevonium WHO ATC
0-L A03AB14 pipenzolate WHO ATC
0-L A03AB15 diphemanil WHO ATC
0-L A03AB16 (2-benzhydryloxyethyl)diethyl-methylammonium iodide WHO ATC
0-L A03AB17 tiemonium iodide WHO ATC
0-L A03AB18 prifinium bromide WHO ATC
0-L A03AB19 timepidium bromide WHO ATC
0-L A03AB21 fenpiverinium WHO ATC
0-L A03AB53 oxyphenonium, combinations WHO ATC
0-L A03AC Synthetic antispasmodics, amides with tertiary amines WHO ATC
0-L A03AC02 dimethylaminopropionylphenothiazine WHO ATC
0-L A03AC04 nicofetamide WHO ATC
0-L A03AC05 tiropramide WHO ATC
0-L A03AD Papaverine and derivatives WHO ATC
0-L A03AD01 papaverine WHO ATC
0-L A03AD02 drotaverine WHO ATC
0-L A03AD30 moxaverine WHO ATC
0-L A03AE Drugs acting on serotonin receptors WHO ATC
0-L A03AE01 alosetron WHO ATC
0-L A03AE02 tegaserod WHO ATC
0-L A03AE03 cilansetron WHO ATC
0-L A03AE04 prucalopride WHO ATC
0-L A03AX Other drugs for functional bowel disorders WHO ATC
0-L A03AX01 fenpiprane WHO ATC
0-L A03AX02 diisopromine WHO ATC
0-L A03AX03 chlorbenzoxamine WHO ATC
0-L A03AX04 pinaverium WHO ATC
0-L A03AX05 fenoverine WHO ATC
0-L A03AX06 idanpramine WHO ATC
0-L A03AX07 proxazole WHO ATC
0-L A03AX08 alverine WHO ATC
0-L A03AX09 trepibutone WHO ATC
0-L A03AX10 isometheptene WHO ATC
0-L A03AX11 caroverine WHO ATC
0-L A03AX12 phloroglucinol WHO ATC
0-L A03AX13 silicones WHO ATC
0-L A03AX30 trimethyldiphenylpropylamine WHO ATC
0-L A03AX58 alverine, combinations WHO ATC
0-L A03B BELLADONNA AND DERIVATIVES, PLAIN WHO ATC
0-L A03BA Belladonna alkaloids, tertiary amines WHO ATC
0-L A03BA01 atropine WHO ATC
0-L A03BA03 hyoscyamine WHO ATC
0-L A03BA04 belladonna total alkaloids WHO ATC
0-L A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds WHO ATC
0-L A03BB01 butylscopolamine WHO ATC
0-L A03BB02 methylatropine WHO ATC
0-L A03BB03 methylscopolamine WHO ATC
0-L A03BB04 fentonium WHO ATC
0-L A03BB05 cimetropium bromide WHO ATC
0-L A03C ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS WHO ATC
0-L A03CA Synthetic anticholinergic agents in combination with psycholeptics WHO ATC
0-L A03CA01 isopropamide and psycholeptics WHO ATC
0-L A03CA02 clidinium and psycholeptics WHO ATC
0-L A03CA03 oxyphencyclimine and psycholeptics WHO ATC
0-L A03CA04 otilonium bromide and psycholeptics WHO ATC
0-L A03CA05 glycopyrronium and psycholeptics WHO ATC
0-L A03CA06 bevonium and psycholeptics WHO ATC
0-L A03CA07 ambutonium and psycholeptics WHO ATC
0-L A03CA08 diphemanil and psycholeptics WHO ATC
0-L A03CA30 emepronium and psycholeptics WHO ATC
0-L A03CA34 propantheline and psycholeptics WHO ATC
0-L A03CB Belladonna and derivatives in combination with psycholeptics WHO ATC
0-L A03CB01 methylscopolamine and psycholeptics WHO ATC
0-L A03CB02 belladonna total alkaloids and psycholeptics WHO ATC
0-L A03CB03 atropine and psycholeptics WHO ATC
0-L A03CB04 methylhomatropine and psycholeptics WHO ATC
0-L A03CB31 hyoscyamine and psycholeptics WHO ATC
0-L A03CC Other antispasmodics in combination with psycholeptics WHO ATC
0-L A03D ANTISPASMODICS IN COMBINATION WITH ANALGESICS WHO ATC
0-L A03DA Synthetic anticholinergic agents in combination with analgesics WHO ATC
0-L A03DA01 tropenzilone and analgesics WHO ATC
0-L A03DA02 pitofenone and analgesics WHO ATC
0-L A03DA03 bevonium and analgesics WHO ATC
0-L A03DA04 ciclonium and analgesics WHO ATC
0-L A03DA05 camylofin and analgesics WHO ATC
0-L A03DA06 trospium and analgesics WHO ATC
0-L A03DA07 tiemonium iodide and analgesics WHO ATC
0-L A03DB Belladonna and derivatives in combination with analgesics WHO ATC
0-L A03DB04 butylscopolamine and analgesics WHO ATC
0-L A03DC Other antispasmodics in combination with analgesics WHO ATC
0-L A03E ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS WHO ATC
0-L A03EA Antispasmodics, psycholeptics and analgesics in combination WHO ATC
0-L A03ED Antispasmodics in combination with other drugs WHO ATC
0-L A03F PROPULSIVES WHO ATC
0-L A03FA Propulsives WHO ATC
0-L A03FA01 metoclopramide WHO ATC
0-L A03FA02 cisapride WHO ATC
0-L A03FA03 domperidone WHO ATC
0-L A03FA04 bromopride WHO ATC
0-L A03FA05 alizapride WHO ATC
0-L A03FA06 clebopride WHO ATC
0-L A04 ANTIEMETICS AND ANTINAUSEANTS WHO ATC
0-L A04A ANTIEMETICS AND ANTINAUSEANTS WHO ATC
0-L A04AA Serotonin (5HT3) antagonists WHO ATC
0-L A04AA01 ondansetron WHO ATC
0-L A04AA02 granisetron WHO ATC
0-L A04AA03 tropisetron WHO ATC
0-L A04AA04 dolasetron WHO ATC
0-L A04AA05 palonosetron WHO ATC
0-L A04AD Other antiemetics WHO ATC
0-L A04AD01 scopolamine WHO ATC
0-L A04AD02 cerium oxalate WHO ATC
0-L A04AD04 chlorobutanol WHO ATC
0-L A04AD05 metopimazine WHO ATC
0-L A04AD10 dronabinol WHO ATC
0-L A04AD11 nabilone WHO ATC
0-L A04AD12 aprepitant WHO ATC
0-L A04AD13 casopitant WHO ATC
0-L A04AD51 scopolamine, combinations WHO ATC
0-L A04AD54 chlorobutanol, combinations WHO ATC
0-L A05 BILE AND LIVER THERAPY WHO ATC
0-L A05A BILE THERAPY WHO ATC
0-L A05AA Bile acid preparations WHO ATC
0-L A05AA01 chenodeoxycholic acid WHO ATC
0-L A05AA02 ursodeoxycholic acid WHO ATC
0-L A05AA03 cholic acid WHO ATC
0-L A05AB Preparations for biliary tract therapy WHO ATC
0-L A05AB01 nicotinyl methylamide WHO ATC
0-L A05AX Other drugs for bile therapy WHO ATC
0-L A05AX01 piprozolin WHO ATC
0-L A05AX02 hymecromone WHO ATC
0-L A05AX03 cyclobutyrol WHO ATC
0-L A05B LIVER THERAPY, LIPOTROPICS WHO ATC
0-L A05BA Liver therapy WHO ATC
0-L A05BA01 arginine glutamate WHO ATC
0-L A05BA03 silymarin WHO ATC
0-L A05BA04 citiolone WHO ATC
0-L A05BA05 epomediol WHO ATC
0-L A05BA06 ornithine oxoglurate WHO ATC
0-L A05BA07 tidiacic arginine WHO ATC
0-L A05BA08 glycyrrhizic acid WHO ATC
0-L A05C DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION WHO ATC
0-L A06 LAXATIVES WHO ATC
0-L A06A LAXATIVES WHO ATC
0-L A06AA Softeners, emollients WHO ATC
0-L A06AA01 liquid paraffin WHO ATC
0-L A06AA02 docusate sodium WHO ATC
0-L A06AA51 liquid paraffin, combinations WHO ATC
0-L A06AB Contact laxatives WHO ATC
0-L A06AB01 oxyphenisatine WHO ATC
0-L A06AB02 bisacodyl WHO ATC
0-L A06AB03 dantron WHO ATC
0-L A06AB04 phenolphthalein WHO ATC
0-L A06AB05 castor oil WHO ATC
0-L A06AB06 senna glycosides WHO ATC
0-L A06AB07 cascara WHO ATC
0-L A06AB08 sodium picosulfate WHO ATC
0-L A06AB09 bisoxatin WHO ATC
0-L A06AB20 contact laxatives in combination WHO ATC
0-L A06AB30 contact laxatives in combination with belladonna alkaloids WHO ATC
0-L A06AB52 bisacodyl, combinations WHO ATC
0-L A06AB53 dantron, combinations WHO ATC
0-L A06AB56 senna glycosides, combinations WHO ATC
0-L A06AB57 cascara, combinations WHO ATC
0-L A06AB58 sodium picosulfate, combinations WHO ATC
0-L A06AC Bulk producers WHO ATC
0-L A06AC01 ispaghula (psylla seeds) WHO ATC
0-L A06AC02 ethulose WHO ATC
0-L A06AC03 sterculia WHO ATC
0-L A06AC05 linseed WHO ATC
0-L A06AC06 methylcellulose WHO ATC
0-L A06AC07 triticum (wheat fibre) WHO ATC
0-L A06AC08 polycarbophil calcium WHO ATC
0-L A06AC51 ispaghula, combinations WHO ATC
0-L A06AC53 sterculia, combinations WHO ATC
0-L A06AC55 linseed, combinations WHO ATC
0-L A06AD Osmotically acting laxatives WHO ATC
0-L A06AD01 magnesium carbonate WHO ATC
0-L A06AD02 magnesium oxide WHO ATC
0-L A06AD03 magnesium peroxide WHO ATC
0-L A06AD04 magnesium sulfate WHO ATC
0-L A06AD10 mineral salts in combination WHO ATC
0-L A06AD11 lactulose WHO ATC
0-L A06AD12 lactitol WHO ATC
0-L A06AD13 sodium sulfate WHO ATC
0-L A06AD14 pentaerithrityl WHO ATC
0-L A06AD15 macrogol WHO ATC
0-L A06AD16 mannitol WHO ATC
0-L A06AD17 sodium phosphate WHO ATC
0-L A06AD18 sorbitol WHO ATC
0-L A06AD19 magnesium citrate WHO ATC
0-L A06AD21 sodium tartrate WHO ATC
0-L A06AD61 lactulose, combinations WHO ATC
0-L A06AD65 macrogol, combinations WHO ATC
0-L A06AG Enemas WHO ATC
0-L A06AG01 sodium phosphate WHO ATC
0-L A06AG02 bisacodyl WHO ATC
0-L A06AG03 dantron, incl. combinations WHO ATC
0-L A06AG04 glycerol WHO ATC
0-L A06AG06 oil WHO ATC
0-L A06AG07 sorbitol WHO ATC
0-L A06AG10 docusate sodium, incl. combinations WHO ATC
0-L A06AG11 laurilsulfate, incl. combinations WHO ATC
0-L A06AG20 combinations WHO ATC
0-L A06AH Peripheral opioid receptor antagonists WHO ATC
0-L A06AH01 methylnaltrexone bromide WHO ATC
0-L A06AH02 alvimopan WHO ATC
0-L A06AX Other laxatives WHO ATC
0-L A06AX01 glycerol WHO ATC
0-L A06AX02 carbon dioxide producing drugs WHO ATC
0-L A06AX03 lubiprostone WHO ATC
0-L A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVEAGENTS WHO ATC
0-L A07A INTESTINAL ANTIINFECTIVES WHO ATC
0-L A07AA Antibiotics WHO ATC
0-L A07AA01 neomycin WHO ATC
0-L A07AA02 nystatin WHO ATC
0-L A07AA03 natamycin WHO ATC
0-L A07AA04 streptomycin WHO ATC
0-L A07AA05 polymyxin B WHO ATC
0-L A07AA06 paromomycin WHO ATC
0-L A07AA07 amphotericin B WHO ATC
0-L A07AA08 kanamycin WHO ATC
0-L A07AA09 vancomycin WHO ATC
0-L A07AA10 colistin WHO ATC
0-L A07AA11 rifaximin WHO ATC
0-L A07AA51 neomycin, combinations WHO ATC
0-L A07AA54 streptomycin, combinations WHO ATC
0-L A07AB Sulfonamides WHO ATC
0-L A07AB02 phthalylsulfathiazole WHO ATC
0-L A07AB03 sulfaguanidine WHO ATC
0-L A07AB04 succinylsulfathiazole WHO ATC
0-L A07AC Imidazole derivatives WHO ATC
0-L A07AC01 miconazole WHO ATC
0-L A07AX Other intestinal antiinfectives WHO ATC
0-L A07AX01 broxyquinoline WHO ATC
0-L A07AX02 acetarsol WHO ATC
0-L A07AX03 nifuroxazide WHO ATC
0-L A07AX04 nifurzide WHO ATC
0-L A07B INTESTINAL ADSORBENTS WHO ATC
0-L A07BA Charcoal preparations WHO ATC
0-L A07BA01 medicinal charcoal WHO ATC
0-L A07BA51 medicinal charcoal, combinations WHO ATC
0-L A07BB Bismuth preparations WHO ATC
0-L A07BC Other intestinal adsorbents WHO ATC
0-L A07BC01 pectin WHO ATC
0-L A07BC02 kaolin WHO ATC
0-L A07BC03 crospovidone WHO ATC
0-L A07BC04 attapulgite WHO ATC
0-L A07BC05 diosmectite WHO ATC
0-L A07BC30 combinations WHO ATC
0-L A07BC54 attapulgite, combinations WHO ATC
0-L A07C ELECTROLYTES WITH CARBOHYDRATES WHO ATC
0-L A07CA Oral rehydration salt formulations WHO ATC
0-L A07D ANTIPROPULSIVES WHO ATC
0-L A07DA Antipropulsives WHO ATC
0-L A07DA01 diphenoxylate WHO ATC
0-L A07DA02 opium WHO ATC
0-L A07DA03 loperamide WHO ATC
0-L A07DA04 difenoxin WHO ATC
0-L A07DA05 loperamide oxide WHO ATC
0-L A07DA52 morphine, combinations WHO ATC
0-L A07DA53 loperamide, combinations WHO ATC
0-L A07E INTESTINAL ANTIINFLAMMATORY AGENTS WHO ATC
0-L A07EA Corticosteroids acting locally WHO ATC
0-L A07EA01 prednisolone WHO ATC
0-L A07EA02 hydrocortisone WHO ATC
0-L A07EA03 prednisone WHO ATC
0-L A07EA04 betamethasone WHO ATC
0-L A07EA05 tixocortol WHO ATC
0-L A07EA06 budesonide WHO ATC
0-L A07EA07 beclometasone WHO ATC
0-L A07EB Antiallergic agents, excl. corticosteroids WHO ATC
0-L A07EB01 cromoglicic acid WHO ATC
0-L A07EC Aminosalicylic acid and similar agents WHO ATC
0-L A07EC01 sulfasalazine WHO ATC
0-L A07EC02 mesalazine WHO ATC
0-L A07EC03 olsalazine WHO ATC
0-L A07EC04 balsalazide WHO ATC
0-L A07F ANTIDIARRHEAL MICROORGANISMS WHO ATC
0-L A07FA Antidiarrheal microorganisms WHO ATC
0-L A07FA01 lactic acid producing organisms WHO ATC
0-L A07FA02 saccharomyces boulardii WHO ATC
0-L A07FA51 lactic acid producing organisms, combinations WHO ATC
0-L A07X OTHER ANTIDIARRHEALS WHO ATC
0-L A07XA Other antidiarrheals WHO ATC
0-L A07XA01 albumin tannate WHO ATC
0-L A07XA02 ceratonia WHO ATC
0-L A07XA03 calcium compounds WHO ATC
0-L A07XA04 racecadotril WHO ATC
0-L A07XA51 albumin tannate, combinations WHO ATC
0-L A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS WHO ATC
0-L A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS WHO ATC
0-L A08AA Centrally acting antiobesity products WHO ATC
0-L A08AA01 phentermine WHO ATC
0-L A08AA02 fenfluramine WHO ATC
0-L A08AA03 amfepramone WHO ATC
0-L A08AA04 dexfenfluramine WHO ATC
0-L A08AA05 mazindol WHO ATC
0-L A08AA06 etilamfetamine WHO ATC
0-L A08AA07 cathine WHO ATC
0-L A08AA08 clobenzorex WHO ATC
0-L A08AA09 mefenorex WHO ATC
0-L A08AA10 sibutramine WHO ATC
0-L A08AA56 ephedrine, combinations WHO ATC
0-L A08AB Peripherally acting antiobesity products WHO ATC
0-L A08AB01 orlistat WHO ATC
0-L A08AX Other antiobesity drugs WHO ATC
0-L A08AX01 rimonabant WHO ATC
0-L A09 DIGESTIVES, INCL. ENZYMES WHO ATC
0-L A09A DIGESTIVES, INCL. ENZYMES WHO ATC
0-L A09AA Enzyme preparations WHO ATC
0-L A09AA01 diastase WHO ATC
0-L A09AA02 multienzymes (lipase, protease etc.) WHO ATC
0-L A09AA03 pepsin WHO ATC
0-L A09AA04 tilactase WHO ATC
0-L A09AB Acid preparations WHO ATC
0-L A09AB01 glutamic acid hydrochloride WHO ATC
0-L A09AB02 betaine hydrochloride WHO ATC
0-L A09AB03 hydrochloric acid WHO ATC
0-L A09AB04 citric acid WHO ATC
0-L A09AC Enzyme and acid preparations, combinations WHO ATC
0-L A09AC01 pepsin and acid preparations WHO ATC
0-L A09AC02 multienzymes and acid preparations WHO ATC
0-L A10 DRUGS USED IN DIABETES WHO ATC
0-L A10A INSULINS AND ANALOGUES WHO ATC
0-L A10AB Insulins and analogues for injection, fast-acting WHO ATC
0-L A10AB01 insulin (human) WHO ATC
0-L A10AB02 insulin (beef) WHO ATC
0-L A10AB03 insulin (pork) WHO ATC
0-L A10AB04 insulin lispro WHO ATC
0-L A10AB05 insulin aspart WHO ATC
0-L A10AB06 insulin glulisine WHO ATC
0-L A10AB30 combinations WHO ATC
0-L A10AC Insulins and analogues for injection, intermediate-acting WHO ATC
0-L A10AC01 insulin (human) WHO ATC
0-L A10AC02 insulin (beef) WHO ATC
0-L A10AC03 insulin (pork) WHO ATC
0-L A10AC04 insulin lispro WHO ATC
0-L A10AC30 combinations WHO ATC
0-L A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting WHO ATC
0-L A10AD01 insulin (human) WHO ATC
0-L A10AD02 insulin (beef) WHO ATC
0-L A10AD03 insulin (pork) WHO ATC
0-L A10AD04 Insulin lispro WHO ATC
0-L A10AD05 insulin aspart WHO ATC
0-L A10AD30 combinations WHO ATC
0-L A10AE Insulins and analogues for injection, long-acting WHO ATC
0-L A10AE01 insulin (human) WHO ATC
0-L A10AE02 insulin (beef) WHO ATC
0-L A10AE03 insulin (pork) WHO ATC
0-L A10AE04 insulin glargine WHO ATC
0-L A10AE05 insulin detemir WHO ATC
0-L A10AE30 combinations WHO ATC
0-L A10AF Insulins and analogues for inhalation WHO ATC
0-L A10AF01 insulin (human) WHO ATC
0-L A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS WHO ATC
0-L A10BA Biguanides WHO ATC
0-L A10BA01 phenformin WHO ATC
0-L A10BA02 metformin WHO ATC
0-L A10BA03 buformin WHO ATC
0-L A10BB Sulfonamides, urea derivatives WHO ATC
0-L A10BB01 glibenclamide WHO ATC
0-L A10BB02 chlorpropamide WHO ATC
0-L A10BB03 tolbutamide WHO ATC
0-L A10BB04 glibornuride WHO ATC
0-L A10BB05 tolazamide WHO ATC
0-L A10BB06 carbutamide WHO ATC
0-L A10BB07 glipizide WHO ATC
0-L A10BB08 gliquidone WHO ATC
0-L A10BB09 gliclazide WHO ATC
0-L A10BB10 metahexamide WHO ATC
0-L A10BB11 glisoxepide WHO ATC
0-L A10BB12 glimepiride WHO ATC
0-L A10BB31 acetohexamide WHO ATC
0-L A10BC Sulfonamides (heterocyclic) WHO ATC
0-L A10BC01 glymidine WHO ATC
0-L A10BD Combinations of oral blood glucose lowering drugs WHO ATC
0-L A10BD01 phenformin and sulfonamides WHO ATC
0-L A10BD02 metformin and sulfonamides WHO ATC
0-L A10BD03 metformin and rosiglitazone WHO ATC
0-L A10BD04 glimepiride and rosiglitazone WHO ATC
0-L A10BD05 metformin and pioglitazone WHO ATC
0-L A10BD06 glimepiride and pioglitazone WHO ATC
0-L A10BD07 metformin and sitagliptin WHO ATC
0-L A10BD08 metformin and vildagliptin WHO ATC
0-L A10BD09 pioglitazone and alogliptin WHO ATC
0-L A10BF Alpha glucosidase inhibitors WHO ATC
0-L A10BF01 acarbose WHO ATC
0-L A10BF02 miglitol WHO ATC
0-L A10BF03 voglibose WHO ATC
0-L A10BG Thiazolidinediones WHO ATC
0-L A10BG01 troglitazone WHO ATC
0-L A10BG02 rosiglitazone WHO ATC
0-L A10BG03 pioglitazone WHO ATC
0-L A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors WHO ATC
0-L A10BH01 sitagliptin WHO ATC
0-L A10BH02 vildagliptin WHO ATC
0-L A10BH03 saxagliptin WHO ATC
0-L A10BH04 alogliptin WHO ATC
0-L A10BX Other blood glucose lowering drugs, excl. insulins WHO ATC
0-L A10BX01 guar gum WHO ATC
0-L A10BX02 repaglinide WHO ATC
0-L A10BX03 nateglinide WHO ATC
0-L A10BX04 exenatide WHO ATC
0-L A10BX05 pramlintide WHO ATC
0-L A10BX06 benfluorex WHO ATC
0-L A10BX07 liraglutide WHO ATC
0-L A10BX08 mitiglinide WHO ATC
0-L A10X OTHER DRUGS USED IN DIABETES WHO ATC
0-L A10XA Aldose reductase inhibitors WHO ATC
0-L A10XA01 tolrestat WHO ATC
0-L A11 VITAMINS WHO ATC
0-L A11A MULTIVITAMINS, COMBINATIONS WHO ATC
0-L A11AA Multivitamins with minerals WHO ATC
0-L A11AA01 multivitamins and iron WHO ATC
0-L A11AA02 multivitamins and calcium WHO ATC
0-L A11AA03 multivitamins and other minerals, incl. combinations WHO ATC
0-L A11AA04 multivitamins and trace elements WHO ATC
0-L A11AB Multivitamins, other combinations WHO ATC
0-L A11B MULTIVITAMINS, PLAIN WHO ATC
0-L A11BA Multivitamins, plain WHO ATC
0-L A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO WHO ATC
0-L A11CA Vitamin A, plain WHO ATC
0-L A11CA01 retinol (vit A) WHO ATC
0-L A11CA02 betacarotene WHO ATC
0-L A11CB Vitamin A and D in combination WHO ATC
0-L A11CC Vitamin D and analogues WHO ATC
0-L A11CC01 ergocalciferol WHO ATC
0-L A11CC02 dihydrotachysterol WHO ATC
0-L A11CC03 alfacalcidol WHO ATC
0-L A11CC04 calcitriol WHO ATC
0-L A11CC05 colecalciferol WHO ATC
0-L A11CC06 calcifediol WHO ATC
0-L A11CC20 combinations WHO ATC
0-L A11D VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 WHO ATC
0-L A11DA Vitamin B1, plain WHO ATC
0-L A11DA01 thiamine (vit B1) WHO ATC
0-L A11DA02 sulbutiamine WHO ATC
0-L A11DA03 benfotiamine WHO ATC
0-L A11DB Vitamin B1 in combination with vitamin B6 and/or vitamin B12 WHO ATC
0-L A11E VITAMIN B-COMPLEX, INCL. COMBINATIONS WHO ATC
0-L A11EA Vitamin B-complex, plain WHO ATC
0-L A11EB Vitamin B-complex with vitamin C WHO ATC
0-L A11EC Vitamin B-complex with minerals WHO ATC
0-L A11ED Vitamin B-complex with anabolic steroids WHO ATC
0-L A11EX Vitamin B-complex, other combinations WHO ATC
0-L A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS WHO ATC
0-L A11GA Ascorbic acid (vitamin C), plain WHO ATC
0-L A11GA01 ascorbic acid (vit C) WHO ATC
0-L A11GB Ascorbic acid (vitamin C), combinations WHO ATC
0-L A11GB01 ascorbic acid (vit C) and calcium WHO ATC
0-L A11H OTHER PLAIN VITAMIN PREPARATIONS WHO ATC
0-L A11HA Other plain vitamin preparations WHO ATC
0-L A11HA01 nicotinamide WHO ATC
0-L A11HA02 pyridoxine (vit B6) WHO ATC
0-L A11HA03 tocopherol (vit E) WHO ATC
0-L A11HA04 riboflavin (vit B2) WHO ATC
0-L A11HA05 biotin WHO ATC
0-L A11HA06 pyridoxal phosphate WHO ATC
0-L A11HA07 inositol WHO ATC
0-L A11HA08 tocofersolan WHO ATC
0-L A11HA30 dexpanthenol WHO ATC
0-L A11HA31 calcium pantothenate WHO ATC
0-L A11HA32 pantethine WHO ATC
0-L A11J OTHER VITAMIN PRODUCTS, COMBINATIONS WHO ATC
0-L A11JA Combinations of vitamins WHO ATC
0-L A11JB Vitamins with minerals WHO ATC
0-L A11JC Vitamins, other combinations WHO ATC
0-L A12 MINERAL SUPPLEMENTS WHO ATC
0-L A12A CALCIUM WHO ATC
0-L A12AA Calcium WHO ATC
0-L A12AA01 calcium phosphate WHO ATC
0-L A12AA02 calcium glubionate WHO ATC
0-L A12AA03 calcium gluconate WHO ATC
0-L A12AA04 calcium carbonate WHO ATC
0-L A12AA05 calcium lactate WHO ATC
0-L A12AA06 calcium lactate gluconate WHO ATC
0-L A12AA07 calcium chloride WHO ATC
0-L A12AA08 calcium glycerylphosphate WHO ATC
0-L A12AA09 calcium citrate lysine complex WHO ATC
0-L A12AA10 calcium glucoheptonate WHO ATC
0-L A12AA11 calcium pangamate WHO ATC
0-L A12AA12 calcium acetate anhydrous WHO ATC
0-L A12AA20 calcium (different salts in combination) WHO ATC
0-L A12AA30 calcium laevulate WHO ATC
0-L A12AX Calcium, combinations with other drugs WHO ATC
0-L A12B POTASSIUM WHO ATC
0-L A12BA Potassium WHO ATC
0-L A12BA01 potassium chloride WHO ATC
0-L A12BA02 potassium citrate WHO ATC
0-L A12BA03 potassium hydrogentartrate WHO ATC
0-L A12BA04 potassium hydrogencarbonate WHO ATC
0-L A12BA05 potassium gluconate WHO ATC
0-L A12BA30 combinations WHO ATC
0-L A12BA51 potassium chloride, combinations WHO ATC
0-L A12C OTHER MINERAL SUPPLEMENTS WHO ATC
0-L A12CA Sodium WHO ATC
0-L A12CA01 sodium chloride WHO ATC
0-L A12CA02 sodium sulfate WHO ATC
0-L A12CB Zinc WHO ATC
0-L A12CB01 zinc sulfate WHO ATC
0-L A12CB02 zinc gluconate WHO ATC
0-L A12CB03 zinc protein complex WHO ATC
0-L A12CC Magnesium WHO ATC
0-L A12CC01 magnesium chloride WHO ATC
0-L A12CC02 magnesium sulfate WHO ATC
0-L A12CC03 magnesium gluconate WHO ATC
0-L A12CC04 magnesium citrate WHO ATC
0-L A12CC05 magnesium aspartate WHO ATC
0-L A12CC06 magnesium lactate WHO ATC
0-L A12CC07 magnesium levulinate WHO ATC
0-L A12CC08 magnesium pidolate WHO ATC
0-L A12CC09 magnesium orotate WHO ATC
0-L A12CC10 magnesium oxide WHO ATC
0-L A12CC30 magnesium (different salts in combination) WHO ATC
0-L A12CD Fluoride WHO ATC
0-L A12CD01 sodium fluoride WHO ATC
0-L A12CD02 sodium monofluorophosphate WHO ATC
0-L A12CD51 fluoride, combinations WHO ATC
0-L A12CE Selenium WHO ATC
0-L A12CE01 sodium selenate WHO ATC
0-L A12CE02 sodium selenite WHO ATC
0-L A12CX Other mineral products WHO ATC
0-L A13 TONICS WHO ATC
0-L A13A TONICS WHO ATC
0-L A14 ANABOLIC AGENTS FOR SYSTEMIC USE WHO ATC
0-L A14A ANABOLIC STEROIDS WHO ATC
0-L A14AA Androstan derivatives WHO ATC
0-L A14AA01 androstanolone WHO ATC
0-L A14AA02 stanozolol WHO ATC
0-L A14AA03 metandienone WHO ATC
0-L A14AA04 metenolone WHO ATC
0-L A14AA05 oxymetholone WHO ATC
0-L A14AA06 quinbolone WHO ATC
0-L A14AA07 prasterone WHO ATC
0-L A14AA08 oxandrolone WHO ATC
0-L A14AA09 norethandrolone WHO ATC
0-L A14AB Estren derivatives WHO ATC
0-L A14AB01 nandrolone WHO ATC
0-L A14AB02 ethylestrenol WHO ATC
0-L A14AB03 oxabolone cipionate WHO ATC
0-L A14B OTHER ANABOLIC AGENTS WHO ATC
0-L A15 APPETITE STIMULANTS WHO ATC
0-L A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS WHO ATC
0-L A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS WHO ATC
0-L A16AA Amino acids and derivatives WHO ATC
0-L A16AA01 levocarnitine WHO ATC
0-L A16AA02 ademetionine WHO ATC
0-L A16AA03 glutamine WHO ATC
0-L A16AA04 mercaptamine WHO ATC
0-L A16AA05 carglumic acid WHO ATC
0-L A16AA06 betaine WHO ATC
0-L A16AB Enzymes WHO ATC
0-L A16AB01 alglucerase WHO ATC
0-L A16AB02 imiglucerase WHO ATC
0-L A16AB03 agalsidase alfa WHO ATC
0-L A16AB04 agalsidase beta WHO ATC
0-L A16AB05 laronidase WHO ATC
0-L A16AB06 sacrosidase WHO ATC
0-L A16AB07 alglucosidase alfa WHO ATC
0-L A16AB08 galsulfase WHO ATC
0-L A16AB09 idursulfase WHO ATC
0-L A16AX Various alimentary tract and metabolism products WHO ATC
0-L A16AX01 tioctic acid WHO ATC
0-L A16AX02 anethole trithione WHO ATC
0-L A16AX03 sodium phenylbutyrate WHO ATC
0-L A16AX04 nitisinone WHO ATC
0-L A16AX05 zinc acetate WHO ATC
0-L A16AX06 miglustat WHO ATC
0-L A16AX07 sapropterin WHO ATC
0-L B BLOOD AND BLOOD FORMING ORGANS WHO ATC
0-L B01 ANTITHROMBOTIC AGENTS WHO ATC
0-L B01A ANTITHROMBOTIC AGENTS WHO ATC
0-L B01AA Vitamin K antagonists WHO ATC
0-L B01AA01 dicoumarol WHO ATC
0-L B01AA02 phenindione WHO ATC
0-L B01AA03 warfarin WHO ATC
0-L B01AA04 phenprocoumon WHO ATC
0-L B01AA07 acenocoumarol WHO ATC
0-L B01AA08 ethyl biscoumacetate WHO ATC
0-L B01AA09 clorindione WHO ATC
0-L B01AA10 diphenadione WHO ATC
0-L B01AA11 tioclomarol WHO ATC
0-L B01AB Heparin group WHO ATC
0-L B01AB01 heparin WHO ATC
0-L B01AB02 antithrombin III WHO ATC
0-L B01AB04 dalteparin WHO ATC
0-L B01AB05 enoxaparin WHO ATC
0-L B01AB06 nadroparin WHO ATC
0-L B01AB07 parnaparin WHO ATC
0-L B01AB08 reviparin WHO ATC
0-L B01AB09 danaparoid WHO ATC
0-L B01AB10 tinzaparin WHO ATC
0-L B01AB11 sulodexide WHO ATC
0-L B01AB12 bemiparin WHO ATC
0-L B01AB51 heparin, combinations WHO ATC
0-L B01AC Platelet aggregation inhibitors excl. heparin WHO ATC
0-L B01AC01 ditazole WHO ATC
0-L B01AC02 cloricromen WHO ATC
0-L B01AC03 picotamide WHO ATC
0-L B01AC04 clopidogrel WHO ATC
0-L B01AC05 ticlopidine WHO ATC
0-L B01AC06 acetylsalicylic acid WHO ATC
0-L B01AC07 dipyridamole WHO ATC
0-L B01AC08 carbasalate calcium WHO ATC
0-L B01AC09 epoprostenol WHO ATC
0-L B01AC10 indobufen WHO ATC
0-L B01AC11 iloprost WHO ATC
0-L B01AC13 abciximab WHO ATC
0-L B01AC15 aloxiprin WHO ATC
0-L B01AC16 eptifibatide WHO ATC
0-L B01AC17 tirofiban WHO ATC
0-L B01AC18 triflusal WHO ATC
0-L B01AC19 beraprost WHO ATC
0-L B01AC21 treprostinil WHO ATC
0-L B01AC22 prasugrel WHO ATC
0-L B01AC30 combinations WHO ATC
0-L B01AD Enzymes WHO ATC
0-L B01AD01 streptokinase WHO ATC
0-L B01AD02 alteplase WHO ATC
0-L B01AD03 anistreplase WHO ATC
0-L B01AD04 urokinase WHO ATC
0-L B01AD05 fibrinolysin WHO ATC
0-L B01AD06 brinase WHO ATC
0-L B01AD07 reteplase WHO ATC
0-L B01AD08 saruplase WHO ATC
0-L B01AD09 ancrod WHO ATC
0-L B01AD10 drotrecogin alfa (activated) WHO ATC
0-L B01AD11 tenecteplase WHO ATC
0-L B01AD12 protein C WHO ATC
0-L B01AE Direct thrombin inhibitors WHO ATC
0-L B01AE01 desirudin WHO ATC
0-L B01AE02 lepirudin WHO ATC
0-L B01AE03 argatroban WHO ATC
0-L B01AE04 melagatran WHO ATC
0-L B01AE05 ximelagatran WHO ATC
0-L B01AE06 bivalirudin WHO ATC
0-L B01AE07 dabigatran etexilate WHO ATC
0-L B01AX Other antithrombotic agents WHO ATC
0-L B01AX01 defibrotide WHO ATC
0-L B01AX04 dermatan sulfate WHO ATC
0-L B01AX05 fondaparinux WHO ATC
0-L B01AX06 rivaroxaban WHO ATC
0-L B02 ANTIHEMORRHAGICS WHO ATC
0-L B02A ANTIFIBRINOLYTICS WHO ATC
0-L B02AA Amino acids WHO ATC
0-L B02AA01 aminocaproic acid WHO ATC
0-L B02AA02 tranexamic acid WHO ATC
0-L B02AA03 aminomethylbenzoic acid WHO ATC
0-L B02AB Proteinase inhibitors WHO ATC
0-L B02AB01 aprotinin WHO ATC
0-L B02AB02 alfa1 antitrypsin WHO ATC
0-L B02AB03 c1-inhibitor WHO ATC
0-L B02AB04 camostat WHO ATC
0-L B02B VITAMIN K AND OTHER HEMOSTATICS WHO ATC
0-L B02BA Vitamin K WHO ATC
0-L B02BA01 phytomenadione WHO ATC
0-L B02BA02 menadione WHO ATC
0-L B02BB Fibrinogen WHO ATC
0-L B02BB01 human fibrinogen WHO ATC
0-L B02BC Local hemostatics WHO ATC
0-L B02BC01 absorbable gelatin sponge WHO ATC
0-L B02BC02 oxidized cellulose WHO ATC
0-L B02BC03 tetragalacturonic acid hydroxymethylester WHO ATC
0-L B02BC05 adrenalone WHO ATC
0-L B02BC06 thrombin WHO ATC
0-L B02BC07 collagen WHO ATC
0-L B02BC08 calcium alginate WHO ATC
0-L B02BC09 epinephrine WHO ATC
0-L B02BC10 fibrinogen, human WHO ATC
0-L B02BC30 combinations WHO ATC
0-L B02BD Blood coagulation factors WHO ATC
0-L B02BD01 coagulation factor IX, II, VII and X in combination WHO ATC
0-L B02BD02 coagulation factor VIII WHO ATC
0-L B02BD03 factor VIII inhibitor bypassing activity WHO ATC
0-L B02BD04 coagulation factor IX WHO ATC
0-L B02BD05 coagulation factor VII WHO ATC
0-L B02BD06 von Willebrand factor and coagulation factor VIII in combination WHO ATC
0-L B02BD07 coagulation factor XIII WHO ATC
0-L B02BD08 eptacog alfa (activated) WHO ATC
0-L B02BD09 nonacog alfa WHO ATC
0-L B02BD30 thrombin WHO ATC
0-L B02BX Other systemic hemostatics WHO ATC
0-L B02BX01 etamsylate WHO ATC
0-L B02BX02 carbazochrome WHO ATC
0-L B02BX03 batroxobin WHO ATC
0-L B02BX04 romiplostim WHO ATC
0-L B02BX05 eltrombopag WHO ATC
0-L B03 ANTIANEMIC PREPARATIONS WHO ATC
0-L B03A IRON PREPARATIONS WHO ATC
0-L B03AA Iron bivalent, oral preparations WHO ATC
0-L B03AA01 ferrous glycine sulfate WHO ATC
0-L B03AA02 ferrous fumarate WHO ATC
0-L B03AA03 ferrous gluconate WHO ATC
0-L B03AA04 ferrous carbonate WHO ATC
0-L B03AA05 ferrous chloride WHO ATC
0-L B03AA06 ferrous succinate WHO ATC
0-L B03AA07 ferrous sulfate WHO ATC
0-L B03AA08 ferrous tartrate WHO ATC
0-L B03AA09 ferrous aspartate WHO ATC
0-L B03AA10 ferrous ascorbate WHO ATC
0-L B03AA11 ferrous iodine WHO ATC
0-L B03AB Iron trivalent, oral preparations WHO ATC
0-L B03AB01 ferric sodium citrate WHO ATC
0-L B03AB02 saccharated iron oxide WHO ATC
0-L B03AB03 sodium feredetate WHO ATC
0-L B03AB04 ferric hydroxide WHO ATC
0-L B03AB05 dextriferron WHO ATC
0-L B03AB06 ferric citrate WHO ATC
0-L B03AB07 chondroitin sulfate-iron complex WHO ATC
0-L B03AB08 ferric acetyl transferrin WHO ATC
0-L B03AB09 ferric proteinsuccinylate WHO ATC
0-L B03AC Iron trivalent, parenteral preparations WHO ATC
0-L B03AC01 dextriferron WHO ATC
0-L B03AC02 saccharated iron oxide WHO ATC
0-L B03AC03 iron-sorbitol-citric acid complex WHO ATC
0-L B03AC05 ferric sorbitol gluconic acid complex WHO ATC
0-L B03AC06 ferric oxide dextran complex WHO ATC
0-L B03AC07 ferric sodium gluconate complex WHO ATC
0-L B03AD Iron in combination with folic acid WHO ATC
0-L B03AD01 ferrous amino acid complex WHO ATC
0-L B03AD02 ferrous fumarate WHO ATC
0-L B03AD03 ferrous sulfate WHO ATC
0-L B03AD04 dextriferron WHO ATC
0-L B03AE Iron in other combinations WHO ATC
0-L B03AE01 iron, vitamin B12 and folic acid WHO ATC
0-L B03AE02 iron, multivitamins and folic acid WHO ATC
0-L B03AE03 iron and multivitamins WHO ATC
0-L B03AE04 iron, multivitamins and minerals WHO ATC
0-L B03AE10 various combinations WHO ATC
0-L B03B VITAMIN B12 AND FOLIC ACID WHO ATC
0-L B03BA Vitamin B12 (cyanocobalamin and analogues) WHO ATC
0-L B03BA01 cyanocobalamin WHO ATC
0-L B03BA02 cyanocobalamin tannin complex WHO ATC
0-L B03BA03 hydroxocobalamin WHO ATC
0-L B03BA04 cobamamide WHO ATC
0-L B03BA05 mecobalamin WHO ATC
0-L B03BA51 cyanocobalamin, combinations WHO ATC
0-L B03BA53 hydroxocobalamin, combinations WHO ATC
0-L B03BB Folic acid and derivatives WHO ATC
0-L B03BB01 folic acid WHO ATC
0-L B03BB51 folic acid, combinations WHO ATC
0-L B03X OTHER ANTIANEMIC PREPARATIONS WHO ATC
0-L B03XA Other antianemic preparations WHO ATC
0-L B03XA01 erythropoietin WHO ATC
0-L B03XA02 darbepoetin alfa WHO ATC
0-L B03XA03 methoxy polyethylene glycol-epoetin beta WHO ATC
0-L B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS WHO ATC
0-L B05A BLOOD AND RELATED PRODUCTS WHO ATC
0-L B05AA Blood substitutes and plasma protein fractions WHO ATC
0-L B05AA01 albumin WHO ATC
0-L B05AA02 other plasma protein fractions WHO ATC
0-L B05AA03 fluorocarbon blood substitutes WHO ATC
0-L B05AA05 dextran WHO ATC
0-L B05AA06 gelatin agents WHO ATC
0-L B05AA07 hydroxyethylstarch WHO ATC
0-L B05AA08 hemoglobin crosfumaril WHO ATC
0-L B05AA09 hemoglobin raffimer WHO ATC
0-L B05AA10 hemoglobin glutamer (bovine) WHO ATC
0-L B05AX Other blood products WHO ATC
0-L B05AX01 erythrocytes WHO ATC
0-L B05AX02 thrombocytes WHO ATC
0-L B05AX03 blood plasma WHO ATC
0-L B05AX04 stem cells from umbilical cord blood WHO ATC
0-L B05B I.V. SOLUTIONS WHO ATC
0-L B05BA Solutions for parenteral nutrition WHO ATC
0-L B05BA01 amino acids WHO ATC
0-L B05BA02 fat emulsions WHO ATC
0-L B05BA03 carbohydrates WHO ATC
0-L B05BA04 protein hydrolysates WHO ATC
0-L B05BA10 combinations WHO ATC
0-L B05BB Solutions affecting the electrolyte balance WHO ATC
0-L B05BB01 electrolytes WHO ATC
0-L B05BB02 electrolytes with carbohydrates WHO ATC
0-L B05BB03 trometamol WHO ATC
0-L B05BC Solutions producing osmotic diuresis WHO ATC
0-L B05BC01 mannitol WHO ATC
0-L B05BC02 carbamide WHO ATC
0-L B05C IRRIGATING SOLUTIONS WHO ATC
0-L B05CA Antiinfectives WHO ATC
0-L B05CA01 cetylpyridinium WHO ATC
0-L B05CA02 chlorhexidine WHO ATC
0-L B05CA03 nitrofural WHO ATC
0-L B05CA04 sulfamethizole WHO ATC
0-L B05CA05 taurolidine WHO ATC
0-L B05CA06 mandelic acid WHO ATC
0-L B05CA07 noxytiolin WHO ATC
0-L B05CA08 ethacridine lactate WHO ATC
0-L B05CA09 neomycin WHO ATC
0-L B05CA10 combinations WHO ATC
0-L B05CB Salt solutions WHO ATC
0-L B05CB01 sodium chloride WHO ATC
0-L B05CB02 sodium citrate WHO ATC
0-L B05CB03 magnesium citrate WHO ATC
0-L B05CB04 sodium bicarbonate WHO ATC
0-L B05CB10 combinations WHO ATC
0-L B05CX Other irrigating solutions WHO ATC
0-L B05CX01 glucose WHO ATC
0-L B05CX02 sorbitol WHO ATC
0-L B05CX03 glycine WHO ATC
0-L B05CX04 mannitol WHO ATC
0-L B05CX10 combinations WHO ATC
0-L B05D PERITONEAL DIALYTICS WHO ATC
0-L B05DA Isotonic solutions WHO ATC
0-L B05DB Hypertonic solutions WHO ATC
0-L B05X I.V. SOLUTION ADDITIVES WHO ATC
0-L B05XA Electrolyte solutions WHO ATC
0-L B05XA01 potassium chloride WHO ATC
0-L B05XA02 sodium bicarbonate WHO ATC
0-L B05XA03 sodium chloride WHO ATC
0-L B05XA04 ammonium chloride WHO ATC
0-L B05XA05 magnesium sulfate WHO ATC
0-L B05XA06 potassium phosphate, incl. comb. with other potassium salts WHO ATC
0-L B05XA07 calcium chloride WHO ATC
0-L B05XA08 sodium acetate WHO ATC
0-L B05XA09 sodium phosphate WHO ATC
0-L B05XA10 magnesium phosphate WHO ATC
0-L B05XA11 magnesium chloride WHO ATC
0-L B05XA12 zinc chloride WHO ATC
0-L B05XA13 hydrochloric acid WHO ATC
0-L B05XA14 sodium glycerophosphate WHO ATC
0-L B05XA15 potassium lactate WHO ATC
0-L B05XA16 cardioplegia solutions WHO ATC
0-L B05XA17 potassium acetate WHO ATC
0-L B05XA30 combinations of electrolytes WHO ATC
0-L B05XA31 electrolytes in combination with other drugs WHO ATC
0-L B05XB Amino acids WHO ATC
0-L B05XB01 arginine hydrochloride WHO ATC
0-L B05XB02 alanyl glutamine WHO ATC
0-L B05XB03 lysine WHO ATC
0-L B05XC Vitamins WHO ATC
0-L B05XX Other i.v. solution additives WHO ATC
0-L B05XX02 trometamol WHO ATC
0-L B05Z HEMODIALYTICS AND HEMOFILTRATES WHO ATC
0-L B05ZA Hemodialytics, concentrates WHO ATC
0-L B05ZB Hemofiltrates WHO ATC
0-L B06 OTHER HEMATOLOGICAL AGENTS WHO ATC
0-L B06A OTHER HEMATOLOGICAL AGENTS WHO ATC
0-L B06AA Enzymes WHO ATC
0-L B06AA02 fibrinolysin and desoxyribonuclease WHO ATC
0-L B06AA03 hyaluronidase WHO ATC
0-L B06AA04 chymotrypsin WHO ATC
0-L B06AA07 trypsin WHO ATC
0-L B06AA10 desoxyribonuclease WHO ATC
0-L B06AA11 bromelains WHO ATC
0-L B06AA55 streptokinase, combinations WHO ATC
0-L B06AB Other hem products WHO ATC
0-L B06AB01 hematin WHO ATC
0-L C CARDIOVASCULAR SYSTEM WHO ATC
0-L C01 CARDIAC THERAPY WHO ATC
0-L C01A CARDIAC GLYCOSIDES WHO ATC
0-L C01AA Digitalis glycosides WHO ATC
0-L C01AA01 acetyldigitoxin WHO ATC
0-L C01AA02 acetyldigoxin WHO ATC
0-L C01AA03 digitalis leaves WHO ATC
0-L C01AA04 digitoxin WHO ATC
0-L C01AA05 digoxin WHO ATC
0-L C01AA06 lanatoside C WHO ATC
0-L C01AA07 deslanoside WHO ATC
0-L C01AA08 metildigoxin WHO ATC
0-L C01AA09 gitoformate WHO ATC
0-L C01AA52 acetyldigoxin, combinations WHO ATC
0-L C01AB Scilla glycosides WHO ATC
0-L C01AB01 proscillaridin WHO ATC
0-L C01AB51 proscillaridin, combinations WHO ATC
0-L C01AC Strophantus glycosides WHO ATC
0-L C01AC01 g-strophanthin WHO ATC
0-L C01AC03 cymarin WHO ATC
0-L C01AX Other cardiac glycosides WHO ATC
0-L C01AX02 peruvoside WHO ATC
0-L C01B ANTIARRHYTHMICS, CLASS I AND III WHO ATC
0-L C01BA Antiarrhythmics, class Ia WHO ATC
0-L C01BA01 quinidine WHO ATC
0-L C01BA02 procainamide WHO ATC
0-L C01BA03 disopyramide WHO ATC
0-L C01BA04 sparteine WHO ATC
0-L C01BA05 ajmaline WHO ATC
0-L C01BA08 prajmaline WHO ATC
0-L C01BA12 lorajmine WHO ATC
0-L C01BA51 quinidine, combinations excl. psycholeptics WHO ATC
0-L C01BA71 quinidine, combinations with psycholeptics WHO ATC
0-L C01BB Antiarrhythmics, class Ib WHO ATC
0-L C01BB01 lidocaine WHO ATC
0-L C01BB02 mexiletine WHO ATC
0-L C01BB03 tocainide WHO ATC
0-L C01BB04 aprindine WHO ATC
0-L C01BC Antiarrhythmics, class Ic WHO ATC
0-L C01BC03 propafenone WHO ATC
0-L C01BC04 flecainide WHO ATC
0-L C01BC07 lorcainide WHO ATC
0-L C01BC08 encainide WHO ATC
0-L C01BD Antiarrhythmics, class III WHO ATC
0-L C01BD01 amiodarone WHO ATC
0-L C01BD02 bretylium tosilate WHO ATC
0-L C01BD03 bunaftine WHO ATC
0-L C01BD04 dofetilide WHO ATC
0-L C01BD05 ibutilide WHO ATC
0-L C01BD06 tedisamil WHO ATC
0-L C01BG Other class I antiarrhythmics WHO ATC
0-L C01BG01 moracizine WHO ATC
0-L C01BG07 cibenzoline WHO ATC
0-L C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES WHO ATC
0-L C01CA Adrenergic and dopaminergic agents WHO ATC
0-L C01CA01 etilefrine WHO ATC
0-L C01CA02 isoprenaline WHO ATC
0-L C01CA03 norepinephrine WHO ATC
0-L C01CA04 dopamine WHO ATC
0-L C01CA05 norfenefrine WHO ATC
0-L C01CA06 phenylephrine WHO ATC
0-L C01CA07 dobutamine WHO ATC
0-L C01CA08 oxedrine WHO ATC
0-L C01CA09 metaraminol WHO ATC
0-L C01CA10 methoxamine WHO ATC
0-L C01CA11 mephentermine WHO ATC
0-L C01CA12 dimetofrine WHO ATC
0-L C01CA13 prenalterol WHO ATC
0-L C01CA14 dopexamine WHO ATC
0-L C01CA15 gepefrine WHO ATC
0-L C01CA16 ibopamine WHO ATC
0-L C01CA17 midodrine WHO ATC
0-L C01CA18 octopamine WHO ATC
0-L C01CA19 fenoldopam WHO ATC
0-L C01CA21 cafedrine WHO ATC
0-L C01CA22 arbutamine WHO ATC
0-L C01CA23 theodrenaline WHO ATC
0-L C01CA24 epinephrine WHO ATC
0-L C01CA30 combinations WHO ATC
0-L C01CA51 etilefrine, combinations WHO ATC
0-L C01CE Phosphodiesterase inhibitors WHO ATC
0-L C01CE01 amrinone WHO ATC
0-L C01CE02 milrinone WHO ATC
0-L C01CE03 enoximone WHO ATC
0-L C01CE04 bucladesine WHO ATC
0-L C01CX Other cardiac stimulants WHO ATC
0-L C01CX06 angiotensinamide WHO ATC
0-L C01CX07 xamoterol WHO ATC
0-L C01CX08 levosimendan WHO ATC
0-L C01D VASODILATORS USED IN CARDIAC DISEASES WHO ATC
0-L C01DA Organic nitrates WHO ATC
0-L C01DA02 glyceryl trinitrate WHO ATC
0-L C01DA04 methylpropylpropanediol dinitrate WHO ATC
0-L C01DA05 pentaerithrityl tetranitrate WHO ATC
0-L C01DA07 propatylnitrate WHO ATC
0-L C01DA08 isosorbide dinitrate WHO ATC
0-L C01DA09 trolnitrate WHO ATC
0-L C01DA13 eritrityl tetranitrate WHO ATC
0-L C01DA14 isosorbide mononitrate WHO ATC
0-L C01DA20 organic nitrates in combination WHO ATC
0-L C01DA38 tenitramine WHO ATC
0-L C01DA52 glyceryl trinitrate, combinations WHO ATC
0-L C01DA54 methylpropylpropanediol dinitrate, combinations WHO ATC
0-L C01DA55 pentaerithrityl tetranitrate, combinations WHO ATC
0-L C01DA57 propatylnitrate, combinations WHO ATC
0-L C01DA58 isosorbide dinitrate, combinations WHO ATC
0-L C01DA59 trolnitrate, combinations WHO ATC
0-L C01DA63 eritrityl tetranitrate, combinations WHO ATC
0-L C01DA70 organic nitrates in combination with psycholeptics WHO ATC
0-L C01DB Quinolone vasodilators WHO ATC
0-L C01DB01 flosequinan WHO ATC
0-L C01DX Other vasodilators used in cardiac diseases WHO ATC
0-L C01DX01 itramin tosilate WHO ATC
0-L C01DX02 prenylamine WHO ATC
0-L C01DX03 oxyfedrine WHO ATC
0-L C01DX04 benziodarone WHO ATC
0-L C01DX05 carbocromen WHO ATC
0-L C01DX06 hexobendine WHO ATC
0-L C01DX07 etafenone WHO ATC
0-L C01DX08 heptaminol WHO ATC
0-L C01DX09 imolamine WHO ATC
0-L C01DX10 dilazep WHO ATC
0-L C01DX11 trapidil WHO ATC
0-L C01DX12 molsidomine WHO ATC
0-L C01DX13 efloxate WHO ATC
0-L C01DX14 cinepazet WHO ATC
0-L C01DX15 cloridarol WHO ATC
0-L C01DX16 nicorandil WHO ATC
0-L C01DX18 linsidomine WHO ATC
0-L C01DX19 nesiritide WHO ATC
0-L C01DX51 itramin tosilate, combinations WHO ATC
0-L C01DX52 prenylamine, combinations WHO ATC
0-L C01DX53 oxyfedrine, combinations WHO ATC
0-L C01DX54 benziodarone, combinations WHO ATC
0-L C01E OTHER CARDIAC PREPARATIONS WHO ATC
0-L C01EA Prostaglandins WHO ATC
0-L C01EA01 alprostadil WHO ATC
0-L C01EB Other cardiac preparations WHO ATC
0-L C01EB02 camphora WHO ATC
0-L C01EB03 indometacin WHO ATC
0-L C01EB04 crataegus glycosides WHO ATC
0-L C01EB05 creatinolfosfate WHO ATC
0-L C01EB06 fosfocreatine WHO ATC
0-L C01EB07 fructose 1,6-diphosphate WHO ATC
0-L C01EB09 ubidecarenone WHO ATC
0-L C01EB10 adenosine WHO ATC
0-L C01EB11 tiracizine WHO ATC
0-L C01EB13 acadesine WHO ATC
0-L C01EB15 trimetazidine WHO ATC
0-L C01EB16 ibuprofen WHO ATC
0-L C01EB17 ivabradine WHO ATC
0-L C01EB18 ranolazine WHO ATC
0-L C01EB19 icatibant WHO ATC
0-L C01EB21 regadenoson WHO ATC
0-L C01EX Other cardiac combination products WHO ATC
0-L C02 ANTIHYPERTENSIVES WHO ATC
0-L C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING WHO ATC
0-L C02AA Rauwolfia alkaloids WHO ATC
0-L C02AA01 rescinnamine WHO ATC
0-L C02AA02 reserpine WHO ATC
0-L C02AA03 combinations of rauwolfia alkaloids WHO ATC
0-L C02AA04 rauwolfia alkaloids, whole root WHO ATC
0-L C02AA05 deserpidine WHO ATC
0-L C02AA06 methoserpidine WHO ATC
0-L C02AA07 bietaserpine WHO ATC
0-L C02AA52 reserpine, combinations WHO ATC
0-L C02AA53 combinations of rauwolfia alkoloids, combinations WHO ATC
0-L C02AA57 bietaserpine, combinations WHO ATC
0-L C02AB Methyldopa WHO ATC
0-L C02AB01 methyldopa (levorotatory) WHO ATC
0-L C02AB02 methyldopa (racemic) WHO ATC
0-L C02AC Imidazoline receptor agonists WHO ATC
0-L C02AC01 clonidine WHO ATC
0-L C02AC02 guanfacine WHO ATC
0-L C02AC04 tolonidine WHO ATC
0-L C02AC05 moxonidine WHO ATC
0-L C02AC06 rilmenidine WHO ATC
0-L C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING WHO ATC
0-L C02BA Sulfonium derivatives WHO ATC
0-L C02BA01 trimetaphan WHO ATC
0-L C02BB Secondary and tertiary amines WHO ATC
0-L C02BB01 mecamylamine WHO ATC
0-L C02BC Bisquaternary ammonium compounds WHO ATC
0-L C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING WHO ATC
0-L C02CA Alpha-adrenoreceptor antagonists WHO ATC
0-L C02CA01 prazosin WHO ATC
0-L C02CA02 indoramin WHO ATC
0-L C02CA03 trimazosin WHO ATC
0-L C02CA04 doxazosin WHO ATC
0-L C02CA06 urapidil WHO ATC
0-L C02CC Guanidine derivatives WHO ATC
0-L C02CC01 betanidine WHO ATC
0-L C02CC02 guanethidine WHO ATC
0-L C02CC03 guanoxan WHO ATC
0-L C02CC04 debrisoquine WHO ATC
0-L C02CC05 guanoclor WHO ATC
0-L C02CC06 guanazodine WHO ATC
0-L C02CC07 guanoxabenz WHO ATC
0-L C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON WHO ATC
0-L C02DA Thiazide derivatives WHO ATC
0-L C02DA01 diazoxide WHO ATC
0-L C02DB Hydrazinophthalazine derivatives WHO ATC
0-L C02DB01 dihydralazine WHO ATC
0-L C02DB02 hydralazine WHO ATC
0-L C02DB03 endralazine WHO ATC
0-L C02DB04 cadralazine WHO ATC
0-L C02DC Pyrimidine derivatives WHO ATC
0-L C02DC01 minoxidil WHO ATC
0-L C02DD Nitroferricyanide derivatives WHO ATC
0-L C02DD01 nitroprusside WHO ATC
0-L C02DG Guanidine derivatives WHO ATC
0-L C02DG01 pinacidil WHO ATC
0-L C02K OTHER ANTIHYPERTENSIVES WHO ATC
0-L C02KA Alkaloids, excl. rauwolfia WHO ATC
0-L C02KA01 veratrum WHO ATC
0-L C02KB Tyrosine hydroxylase inhibitors WHO ATC
0-L C02KB01 metirosine WHO ATC
0-L C02KC MAO inhibitors WHO ATC
0-L C02KC01 pargyline WHO ATC
0-L C02KD Serotonin antagonists WHO ATC
0-L C02KD01 ketanserin WHO ATC
0-L C02KX Other antihypertensives WHO ATC
0-L C02KX01 bosentan WHO ATC
0-L C02KX02 ambrisentan WHO ATC
0-L C02KX03 sitaxentan WHO ATC
0-L C02L ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION WHO ATC
0-L C02LA Rauwolfia alkaloids and diuretics in combination WHO ATC
0-L C02LA01 reserpine and diuretics WHO ATC
0-L C02LA02 rescinnamine and diuretics WHO ATC
0-L C02LA03 deserpidine and diuretics WHO ATC
0-L C02LA04 methoserpidine and diuretics WHO ATC
0-L C02LA07 bietaserpine and diuretics WHO ATC
0-L C02LA08 rauwolfia alkaloids, whole root and diuretics WHO ATC
0-L C02LA09 syrosingopine and diuretics WHO ATC
0-L C02LA50 comb. of rauwolfia alkaloids and diuretics incl. other combinations WHO ATC
0-L C02LA51 reserpine and diuretics, combinations with other drugs WHO ATC
0-L C02LA52 rescinnamine and diuretics, combinations with other drugs WHO ATC
0-L C02LA71 reserpine and diuretics, combinations with psycholeptics WHO ATC
0-L C02LB Methyldopa and diuretics in combination WHO ATC
0-L C02LB01 methyldopa (levorotatory) and diuretics WHO ATC
0-L C02LC Imidazoline receptor agonists in combination with diuretics WHO ATC
0-L C02LC01 clonidine and diuretics WHO ATC
0-L C02LC05 moxonidine and diuretics WHO ATC
0-L C02LC51 clonidine and diuretics, combinations with other drugs WHO ATC
0-L C02LE Alpha-adrenoreceptor antagonists and diuretics WHO ATC
0-L C02LE01 prazosin and diuretics WHO ATC
0-L C02LF Guanidine derivatives and diuretics WHO ATC
0-L C02LF01 guanethidine and diuretics WHO ATC
0-L C02LG Hydrazinophthalazine derivatives and diuretics WHO ATC
0-L C02LG01 dihydralazine and diuretics WHO ATC
0-L C02LG02 hydralazine and diuretics WHO ATC
0-L C02LG03 picodralazine and diuretics WHO ATC
0-L C02LG51 dihydralazine and diuretics, combinations with other drugs WHO ATC
0-L C02LG73 picodralazine and diuretics, combinations with psycholeptics WHO ATC
0-L C02LK Alkaloids, excl. rauwolfia, in combination with diuretics WHO ATC
0-L C02LK01 veratrum and diuretics WHO ATC
0-L C02LL MAO inhibitors and diuretics WHO ATC
0-L C02LL01 pargyline and diuretics WHO ATC
0-L C02LN Serotonin antagonists and diuretics WHO ATC
0-L C02LX Other antihypertensives and diuretics WHO ATC
0-L C02LX01 pinacidil and diuretics WHO ATC
0-L C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 WHO ATC
0-L C03 DIURETICS WHO ATC
0-L C03A LOW-CEILING DIURETICS, THIAZIDES WHO ATC
0-L C03AA Thiazides, plain WHO ATC
0-L C03AA01 bendroflumethiazide WHO ATC
0-L C03AA02 hydroflumethiazide WHO ATC
0-L C03AA03 hydrochlorothiazide WHO ATC
0-L C03AA04 chlorothiazide WHO ATC
0-L C03AA05 polythiazide WHO ATC
0-L C03AA06 trichlormethiazide WHO ATC
0-L C03AA07 cyclopenthiazide WHO ATC
0-L C03AA08 methyclothiazide WHO ATC
0-L C03AA09 cyclothiazide WHO ATC
0-L C03AA13 mebutizide WHO ATC
0-L C03AB Thiazides and potassium in combination WHO ATC
0-L C03AB01 bendroflumethiazide and potassium WHO ATC
0-L C03AB02 hydroflumethiazide and potassium WHO ATC
0-L C03AB03 hydrochlorothiazide and potassium WHO ATC
0-L C03AB04 chlorothiazide and potassium WHO ATC
0-L C03AB05 polythiazide and potassium WHO ATC
0-L C03AB06 trichlormethiazide and potassium WHO ATC
0-L C03AB07 cyclopenthiazide and potassium WHO ATC
0-L C03AB08 methyclothiazide and potassium WHO ATC
0-L C03AB09 cyclothiazide and potassium WHO ATC
0-L C03AH Thiazides, combinations with psycholeptics and/or analgesics WHO ATC
0-L C03AH01 chlorothiazide, combinations WHO ATC
0-L C03AH02 hydroflumethiazide, combinations WHO ATC
0-L C03AX Thiazides, combinations with other drugs WHO ATC
0-L C03AX01 hydrochlorothiazide, combinations WHO ATC
0-L C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES WHO ATC
0-L C03BA Sulfonamides, plain WHO ATC
0-L C03BA02 quinethazone WHO ATC
0-L C03BA03 clopamide WHO ATC
0-L C03BA04 chlortalidone WHO ATC
0-L C03BA05 mefruside WHO ATC
0-L C03BA07 clofenamide WHO ATC
0-L C03BA08 metolazone WHO ATC
0-L C03BA09 meticrane WHO ATC
0-L C03BA10 xipamide WHO ATC
0-L C03BA11 indapamide WHO ATC
0-L C03BA12 clorexolone WHO ATC
0-L C03BA13 fenquizone WHO ATC
0-L C03BA82 clorexolone, comb. with psycholeptics WHO ATC
0-L C03BB Sulfonamides and potassium in combination WHO ATC
0-L C03BB02 quinethazone and potassium WHO ATC
0-L C03BB03 clopamide and potassium WHO ATC
0-L C03BB04 chlortalidone and potassium WHO ATC
0-L C03BB05 mefruside and potassium WHO ATC
0-L C03BB07 clofenamide and potassium WHO ATC
0-L C03BC Mercurial diuretics WHO ATC
0-L C03BC01 mersalyl WHO ATC
0-L C03BD Xanthine derivatives WHO ATC
0-L C03BD01 theobromine WHO ATC
0-L C03BK Sulfonamides, combinations with other drugs WHO ATC
0-L C03BX Other low-ceiling diuretics WHO ATC
0-L C03BX03 cicletanine WHO ATC
0-L C03C HIGH-CEILING DIURETICS WHO ATC
0-L C03CA Sulfonamides, plain WHO ATC
0-L C03CA01 furosemide WHO ATC
0-L C03CA02 bumetanide WHO ATC
0-L C03CA03 piretanide WHO ATC
0-L C03CA04 torasemide WHO ATC
0-L C03CB Sulfonamides and potassium in combination WHO ATC
0-L C03CB01 furosemide and potassium WHO ATC
0-L C03CB02 bumetanide and potassium WHO ATC
0-L C03CC Aryloxyacetic acid derivatives WHO ATC
0-L C03CC01 etacrynic acid WHO ATC
0-L C03CC02 tienilic acid WHO ATC
0-L C03CD Pyrazolone derivatives WHO ATC
0-L C03CD01 muzolimine WHO ATC
0-L C03CX Other high-ceiling diuretics WHO ATC
0-L C03CX01 etozolin WHO ATC
0-L C03D POTASSIUM-SPARING AGENTS WHO ATC
0-L C03DA Aldosterone antagonists WHO ATC
0-L C03DA01 spironolactone WHO ATC
0-L C03DA02 potassium canrenoate WHO ATC
0-L C03DA03 canrenone WHO ATC
0-L C03DA04 eplerenone WHO ATC
0-L C03DB Other potassium-sparing agents WHO ATC
0-L C03DB01 amiloride WHO ATC
0-L C03DB02 triamterene WHO ATC
0-L C03E DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION WHO ATC
0-L C03EA Low-ceiling diuretics and potassium-sparing agents WHO ATC
0-L C03EA01 hydrochlorothiazide and potassium-sparing agents WHO ATC
0-L C03EA02 trichlormethiazide and potassium-sparing agents WHO ATC
0-L C03EA03 epitizide and potassium-sparing agents WHO ATC
0-L C03EA04 altizide and potassium-sparing agents WHO ATC
0-L C03EA05 mebutizide and potassium-sparing agents WHO ATC
0-L C03EA06 chlortalidone and potassium-sparing agents WHO ATC
0-L C03EA07 cyclopenthiazide and potassium-sparing agents WHO ATC
0-L C03EA12 metolazone and potassium-sparing agents WHO ATC
0-L C03EA13 bendroflumethiazide and potassium-sparing agents WHO ATC
0-L C03EA14 butizide and potassium-sparing agents WHO ATC
0-L C03EB High-ceiling diuretics and potassium-sparing agents WHO ATC
0-L C03EB01 furosemide and potassium-sparing agents WHO ATC
0-L C03EB02 bumetanide and potassium-sparing agents WHO ATC
0-L C03X OTHER DIURETICS WHO ATC
0-L C03XA Vasopressin antagonists WHO ATC
0-L C03XA01 tolvaptan WHO ATC
0-L C03XA02 conivaptan WHO ATC
0-L C04 PERIPHERAL VASODILATORS WHO ATC
0-L C04A PERIPHERAL VASODILATORS WHO ATC
0-L C04AA 2-amino-1-phenylethanol derivatives WHO ATC
0-L C04AA01 isoxsuprine WHO ATC
0-L C04AA02 buphenine WHO ATC
0-L C04AA31 bamethan WHO ATC
0-L C04AB Imidazoline derivatives WHO ATC
0-L C04AB01 phentolamine WHO ATC
0-L C04AB02 tolazoline WHO ATC
0-L C04AC Nicotinic acid and derivatives WHO ATC
0-L C04AC01 nicotinic acid WHO ATC
0-L C04AC02 nicotinyl alcohol (pyridylcarbinol) WHO ATC
0-L C04AC03 inositol nicotinate WHO ATC
0-L C04AC07 ciclonicate WHO ATC
0-L C04AD Purine derivatives WHO ATC
0-L C04AD01 pentifylline WHO ATC
0-L C04AD02 xantinol nicotinate WHO ATC
0-L C04AD03 pentoxifylline WHO ATC
0-L C04AD04 etofylline nicotinate WHO ATC
0-L C04AE Ergot alkaloids WHO ATC
0-L C04AE01 ergoloid mesylates WHO ATC
0-L C04AE02 nicergoline WHO ATC
0-L C04AE04 dihydroergocristine WHO ATC
0-L C04AE51 ergoloid mesylates, combinations WHO ATC
0-L C04AE54 dihydroergocristine, combinations WHO ATC
0-L C04AF Enzymes WHO ATC
0-L C04AF01 kallidinogenase WHO ATC
0-L C04AX Other peripheral vasodilators WHO ATC
0-L C04AX01 cyclandelate WHO ATC
0-L C04AX02 phenoxybenzamine WHO ATC
0-L C04AX07 vincamine WHO ATC
0-L C04AX10 moxisylyte WHO ATC
0-L C04AX11 bencyclane WHO ATC
0-L C04AX17 vinburnine WHO ATC
0-L C04AX19 suloctidil WHO ATC
0-L C04AX20 buflomedil WHO ATC
0-L C04AX21 naftidrofuryl WHO ATC
0-L C04AX23 butalamine WHO ATC
0-L C04AX24 visnadine WHO ATC
0-L C04AX26 cetiedil WHO ATC
0-L C04AX27 cinepazide WHO ATC
0-L C04AX28 ifenprodil WHO ATC
0-L C04AX30 azapetine WHO ATC
0-L C04AX32 fasudil WHO ATC
0-L C05 VASOPROTECTIVES WHO ATC
0-L C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANALFISSURES FOR TOPICAL USE WHO ATC
0-L C05AA Corticosteroids WHO ATC
0-L C05AA01 hydrocortisone WHO ATC
0-L C05AA04 prednisolone WHO ATC
0-L C05AA05 betamethasone WHO ATC
0-L C05AA06 fluorometholone WHO ATC
0-L C05AA08 fluocortolone WHO ATC
0-L C05AA09 dexamethasone WHO ATC
0-L C05AA10 fluocinolone acetonide WHO ATC
0-L C05AA11 fluocinonide WHO ATC
0-L C05AB Antibiotics WHO ATC
0-L C05AD Local anesthetics WHO ATC
0-L C05AD01 lidocaine WHO ATC
0-L C05AD02 tetracaine WHO ATC
0-L C05AD03 benzocaine WHO ATC
0-L C05AD04 cinchocaine WHO ATC
0-L C05AD05 procaine WHO ATC
0-L C05AD06 oxetacaine WHO ATC
0-L C05AD07 pramocaine WHO ATC
0-L C05AE Muscle relaxants WHO ATC
0-L C05AE01 glyceryl trinitrate WHO ATC
0-L C05AE02 isosorbide dinitrate WHO ATC
0-L C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use WHO ATC
0-L C05AX01 aluminium preparations WHO ATC
0-L C05AX02 bismuth preparations, combinations WHO ATC
0-L C05AX03 other preparations, combinations WHO ATC
0-L C05AX04 zinc preparations WHO ATC
0-L C05AX05 tribenoside WHO ATC
0-L C05B ANTIVARICOSE THERAPY WHO ATC
0-L C05BA Heparins or heparinoids for topical use WHO ATC
0-L C05BA01 organo-heparinoid WHO ATC
0-L C05BA02 sodium apolate WHO ATC
0-L C05BA03 heparin WHO ATC
0-L C05BA04 pentosan polysulfate sodium WHO ATC
0-L C05BA51 heparinoid, combinations WHO ATC
0-L C05BA53 heparin, combinations WHO ATC
0-L C05BB Sclerosing agents for local injection WHO ATC
0-L C05BB01 monoethanolamine oleate WHO ATC
0-L C05BB02 polidocanol WHO ATC
0-L C05BB03 invert sugar WHO ATC
0-L C05BB04 sodium tetradecyl sulfate WHO ATC
0-L C05BB05 phenol WHO ATC
0-L C05BB56 glucose, combinations WHO ATC
0-L C05BX Other sclerosing agents WHO ATC
0-L C05BX01 calcium dobesilate WHO ATC
0-L C05BX51 calcium dobesilate, combinations WHO ATC
0-L C05C CAPILLARY STABILIZING AGENTS WHO ATC
0-L C05CA Bioflavonoids WHO ATC
0-L C05CA01 rutoside WHO ATC
0-L C05CA02 monoxerutin WHO ATC
0-L C05CA03 diosmin WHO ATC
0-L C05CA04 troxerutin WHO ATC
0-L C05CA05 hidrosmin WHO ATC
0-L C05CA51 rutoside, combinations WHO ATC
0-L C05CA53 diosmin, combinations WHO ATC
0-L C05CA54 troxerutin, combinations WHO ATC
0-L C05CX Other capillary stabilizing agents WHO ATC
0-L C05CX01 tribenoside WHO ATC
0-L C07 BETA BLOCKING AGENTS WHO ATC
0-L C07A BETA BLOCKING AGENTS WHO ATC
0-L C07AA Beta blocking agents, non-selective WHO ATC
0-L C07AA01 alprenolol WHO ATC
0-L C07AA02 oxprenolol WHO ATC
0-L C07AA03 pindolol WHO ATC
0-L C07AA05 propranolol WHO ATC
0-L C07AA06 timolol WHO ATC
0-L C07AA07 sotalol WHO ATC
0-L C07AA12 nadolol WHO ATC
0-L C07AA14 mepindolol WHO ATC
0-L C07AA15 carteolol WHO ATC
0-L C07AA16 tertatolol WHO ATC
0-L C07AA17 bopindolol WHO ATC
0-L C07AA19 bupranolol WHO ATC
0-L C07AA23 penbutolol WHO ATC
0-L C07AA27 cloranolol WHO ATC
0-L C07AA57 sotalol, combinations WHO ATC
0-L C07AB Beta blocking agents, selective WHO ATC
0-L C07AB01 practolol WHO ATC
0-L C07AB02 metoprolol WHO ATC
0-L C07AB03 atenolol WHO ATC
0-L C07AB04 acebutolol WHO ATC
0-L C07AB05 betaxolol WHO ATC
0-L C07AB06 bevantolol WHO ATC
0-L C07AB07 bisoprolol WHO ATC
0-L C07AB08 celiprolol WHO ATC
0-L C07AB09 esmolol WHO ATC
0-L C07AB10 epanolol WHO ATC
0-L C07AB11 s-atenolol WHO ATC
0-L C07AB12 nebivolol WHO ATC
0-L C07AB13 talinolol WHO ATC
0-L C07AB52 metoprolol, combinations WHO ATC
0-L C07AB57 bisoprolol, combinations WHO ATC
0-L C07AG Alpha and beta blocking agents WHO ATC
0-L C07AG01 labetalol WHO ATC
0-L C07AG02 carvedilol WHO ATC
0-L C07B BETA BLOCKING AGENTS AND THIAZIDES WHO ATC
0-L C07BA Beta blocking agents, non-selective, and thiazides WHO ATC
0-L C07BA02 oxprenolol and thiazides WHO ATC
0-L C07BA05 propranolol and thiazides WHO ATC
0-L C07BA06 timolol and thiazides WHO ATC
0-L C07BA07 sotalol and thiazides WHO ATC
0-L C07BA12 nadolol and thiazides WHO ATC
0-L C07BA68 metipranolol and thiazides, combinations WHO ATC
0-L C07BB Beta blocking agents, selective, and thiazides WHO ATC
0-L C07BB02 metoprolol and thiazides WHO ATC
0-L C07BB03 atenolol and thiazides WHO ATC
0-L C07BB04 acebutolol and thiazides WHO ATC
0-L C07BB06 bevantolol and thiazides WHO ATC
0-L C07BB07 bisoprolol and thiazides WHO ATC
0-L C07BB52 metoprolol and thiazides, combinations WHO ATC
0-L C07BG Alpha and beta blocking agents and thiazides WHO ATC
0-L C07BG01 labetalol and thiazides WHO ATC
0-L C07C BETA BLOCKING AGENTS AND OTHER DIURETICS WHO ATC
0-L C07CA Beta blocking agents, non-selective, and other diuretics WHO ATC
0-L C07CA02 oxprenolol and other diuretics WHO ATC
0-L C07CA03 pindolol and other diuretics WHO ATC
0-L C07CA17 bopindolol and other diuretics WHO ATC
0-L C07CA23 penbutolol and other diuretics WHO ATC
0-L C07CB Beta blocking agents, selective, and other diuretics WHO ATC
0-L C07CB02 metoprolol and other diuretics WHO ATC
0-L C07CB03 atenolol and other diuretics WHO ATC
0-L C07CB53 atenolol and other diuretics, combinations WHO ATC
0-L C07CG Alpha and beta blocking agents and other diuretics WHO ATC
0-L C07CG01 labetalol and other diuretics WHO ATC
0-L C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS WHO ATC
0-L C07DA Beta blocking agents, non-selective, thiazides and other diuretics WHO ATC
0-L C07DA06 timolol, thiazides and other diuretics WHO ATC
0-L C07DB Beta blocking agents, selective, thiazides and other diuretics WHO ATC
0-L C07DB01 atenolol, thiazides and other diuretics WHO ATC
0-L C07E BETA BLOCKING AGENTS AND VASODILATORS WHO ATC
0-L C07EA Beta blocking agents, non-selective, and vasodilators WHO ATC
0-L C07EB Beta blocking agents, selective, and vasodilators WHO ATC
0-L C07F BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES WHO ATC
0-L C07FA Beta blocking agents, non-selective, and other antihypertensives WHO ATC
0-L C07FA05 propranolol and other antihypertensives WHO ATC
0-L C07FB Beta blocking agents, selective, and other antihypertensives WHO ATC
0-L C07FB02 metoprolol and other antihypertensives WHO ATC
0-L C07FB03 atenolol and other antihypertensives WHO ATC
0-L C08 CALCIUM CHANNEL BLOCKERS WHO ATC
0-L C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS WHO ATC
0-L C08CA Dihydropyridine derivatives WHO ATC
0-L C08CA01 amlodipine WHO ATC
0-L C08CA02 felodipine WHO ATC
0-L C08CA03 isradipine WHO ATC
0-L C08CA04 nicardipine WHO ATC
0-L C08CA05 nifedipine WHO ATC
0-L C08CA06 nimodipine WHO ATC
0-L C08CA07 nisoldipine WHO ATC
0-L C08CA08 nitrendipine WHO ATC
0-L C08CA09 lacidipine WHO ATC
0-L C08CA10 nilvadipine WHO ATC
0-L C08CA11 manidipine WHO ATC
0-L C08CA12 barnidipine WHO ATC
0-L C08CA13 lercanidipine WHO ATC
0-L C08CA14 cilnidipine WHO ATC
0-L C08CA15 benidipine WHO ATC
0-L C08CA55 nifedipine, combinations WHO ATC
0-L C08CX Other selective calcium channel blockers with mainly vascular effects WHO ATC
0-L C08CX01 mibefradil WHO ATC
0-L C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS WHO ATC
0-L C08DA Phenylalkylamine derivatives WHO ATC
0-L C08DA01 verapamil WHO ATC
0-L C08DA02 gallopamil WHO ATC
0-L C08DA51 verapamil, combinations WHO ATC
0-L C08DB Benzothiazepine derivatives WHO ATC
0-L C08DB01 diltiazem WHO ATC
0-L C08E NON-SELECTIVE CALCIUM CHANNEL BLOCKERS WHO ATC
0-L C08EA Phenylalkylamine derivatives WHO ATC
0-L C08EA01 fendiline WHO ATC
0-L C08EA02 bepridil WHO ATC
0-L C08EX Other non-selective calcium channel blockers WHO ATC
0-L C08EX01 lidoflazine WHO ATC
0-L C08EX02 perhexiline WHO ATC
0-L C08G CALCIUM CHANNEL BLOCKERS AND DIURETICS WHO ATC
0-L C08GA Calcium channel blockers and diuretics WHO ATC
0-L C08GA01 nifedipine and diuretics WHO ATC
0-L C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM WHO ATC
0-L C09A ACE INHIBITORS, PLAIN WHO ATC
0-L C09AA ACE inhibitors, plain WHO ATC
0-L C09AA01 captopril WHO ATC
0-L C09AA02 enalapril WHO ATC
0-L C09AA03 lisinopril WHO ATC
0-L C09AA04 perindopril WHO ATC
0-L C09AA05 ramipril WHO ATC
0-L C09AA06 quinapril WHO ATC
0-L C09AA07 benazepril WHO ATC
0-L C09AA08 cilazapril WHO ATC
0-L C09AA09 fosinopril WHO ATC
0-L C09AA10 trandolapril WHO ATC
0-L C09AA11 spirapril WHO ATC
0-L C09AA12 delapril WHO ATC
0-L C09AA13 moexipril WHO ATC
0-L C09AA14 temocapril WHO ATC
0-L C09AA15 zofenopril WHO ATC
0-L C09AA16 imidapril WHO ATC
0-L C09B ACE INHIBITORS, COMBINATIONS WHO ATC
0-L C09BA ACE inhibitors and diuretics WHO ATC
0-L C09BA01 captopril and diuretics WHO ATC
0-L C09BA02 enalapril and diuretics WHO ATC
0-L C09BA03 lisinopril and diuretics WHO ATC
0-L C09BA04 perindopril and diuretics WHO ATC
0-L C09BA05 ramipril and diuretics WHO ATC
0-L C09BA06 quinapril and diuretics WHO ATC
0-L C09BA07 benazepril and diuretics WHO ATC
0-L C09BA08 cilazapril and diuretics WHO ATC
0-L C09BA09 fosinopril and diuretics WHO ATC
0-L C09BA12 delapril and diuretics WHO ATC
0-L C09BA13 moexipril and diuretics WHO ATC
0-L C09BA15 zofenopril and diuretics WHO ATC
0-L C09BB ACE inhibitors and calcium channel blockers WHO ATC
0-L C09BB02 enalapril and lercanidipine WHO ATC
0-L C09BB03 lisinopril and amlodipine WHO ATC
0-L C09BB04 perindopril and amlodipine WHO ATC
0-L C09BB05 ramipril and felodipine WHO ATC
0-L C09BB10 trandolapril and verapamil WHO ATC
0-L C09BB12 delapril and manidipine WHO ATC
0-L C09C ANGIOTENSIN II ANTAGONISTS, PLAIN WHO ATC
0-L C09CA Angiotensin II antagonists, plain WHO ATC
0-L C09CA01 losartan WHO ATC
0-L C09CA02 eprosartan WHO ATC
0-L C09CA03 valsartan WHO ATC
0-L C09CA04 irbesartan WHO ATC
0-L C09CA05 tasosartan WHO ATC
0-L C09CA06 candesartan WHO ATC
0-L C09CA07 telmisartan WHO ATC
0-L C09CA08 olmesartan medoxomil WHO ATC
0-L C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS WHO ATC
0-L C09DA Angiotensin II antagonists and diuretics WHO ATC
0-L C09DA01 losartan and diuretics WHO ATC
0-L C09DA02 eprosartan and diuretics WHO ATC
0-L C09DA03 valsartan and diuretics WHO ATC
0-L C09DA04 irbesartan and diuretics WHO ATC
0-L C09DA06 candesartan and diuretics WHO ATC
0-L C09DA07 telmisartan and diuretics WHO ATC
0-L C09DA08 olmesartan medoxomil and diuretics WHO ATC
0-L C09DB Angiotensin II antagonists and calcium channel blockers WHO ATC
0-L C09DB01 valsartan and amlodipine WHO ATC
0-L C09DB02 olmesartan medoxomil and amlodipine WHO ATC
0-L C09DB04 telmisartan and amlodipine WHO ATC
0-L C09DX Angiotensin II antagonists, other combinations WHO ATC
0-L C09DX01 valsartan, amlodipine and hydrochlorothiazide WHO ATC
0-L C09DX02 valsartan and aliskiren WHO ATC
0-L C09X OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM WHO ATC
0-L C09XA Renin-inhibitors WHO ATC
0-L C09XA01 remikiren WHO ATC
0-L C09XA02 aliskiren WHO ATC
0-L C09XA52 aliskiren and hydrochlorothiazide WHO ATC
0-L C10 LIPID MODIFYING AGENTS WHO ATC
0-L C10A LIPID MODIFYING AGENTS, PLAIN WHO ATC
0-L C10AA HMG CoA reductase inhibitors WHO ATC
0-L C10AA01 simvastatin WHO ATC
0-L C10AA02 lovastatin WHO ATC
0-L C10AA03 pravastatin WHO ATC
0-L C10AA04 fluvastatin WHO ATC
0-L C10AA05 atorvastatin WHO ATC
0-L C10AA06 cerivastatin WHO ATC
0-L C10AA07 rosuvastatin WHO ATC
0-L C10AA08 pitavastatin WHO ATC
0-L C10AB Fibrates WHO ATC
0-L C10AB01 clofibrate WHO ATC
0-L C10AB02 bezafibrate WHO ATC
0-L C10AB03 aluminium clofibrate WHO ATC
0-L C10AB04 gemfibrozil WHO ATC
0-L C10AB05 fenofibrate WHO ATC
0-L C10AB06 simfibrate WHO ATC
0-L C10AB07 ronifibrate WHO ATC
0-L C10AB08 ciprofibrate WHO ATC
0-L C10AB09 etofibrate WHO ATC
0-L C10AB10 clofibride WHO ATC
0-L C10AC Bile acid sequestrants WHO ATC
0-L C10AC01 colestyramine WHO ATC
0-L C10AC02 colestipol WHO ATC
0-L C10AC03 colextran WHO ATC
0-L C10AC04 colesevelam WHO ATC
0-L C10AD Nicotinic acid and derivatives WHO ATC
0-L C10AD01 niceritrol WHO ATC
0-L C10AD02 nicotinic acid WHO ATC
0-L C10AD03 nicofuranose WHO ATC
0-L C10AD04 aluminium nicotinate WHO ATC
0-L C10AD05 nicotinyl alcohol (pyridylcarbinol) WHO ATC
0-L C10AD06 acipimox WHO ATC
0-L C10AD52 nicotinic acid, combinations WHO ATC
0-L C10AX Other lipid modifying agents WHO ATC
0-L C10AX01 dextrothyroxine WHO ATC
0-L C10AX02 probucol WHO ATC
0-L C10AX03 tiadenol WHO ATC
0-L C10AX05 meglutol WHO ATC
0-L C10AX06 omega-3-triglycerides incl. other esters and acids WHO ATC
0-L C10AX07 magnesium pyridoxal 5-phosphate glutamate WHO ATC
0-L C10AX08 policosanol WHO ATC
0-L C10AX09 ezetimibe WHO ATC
0-L C10AX10 alipogene tiparvovec WHO ATC
0-L C10B LIPID MODIFYING AGENTS, COMBINATIONS WHO ATC
0-L C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents WHO ATC
0-L C10BA01 lovastatin and nicotinic acid WHO ATC
0-L C10BA02 simvastatin and ezetimibe WHO ATC
0-L C10BA03 pravastatin and fenofibrate WHO ATC
0-L C10BX HMG CoA reductase inhibitors, other combinations WHO ATC
0-L C10BX01 simvastatin and acetylsalicylic acid WHO ATC
0-L C10BX02 pravastatin and acetylsalicylic acid WHO ATC
0-L C10BX03 atorvastatin and amlodipine WHO ATC
0-L D DERMATOLOGICALS WHO ATC
0-L D01 ANTIFUNGALS FOR DERMATOLOGICAL USE WHO ATC
0-L D01A ANTIFUNGALS FOR TOPICAL USE WHO ATC
0-L D01AA Antibiotics WHO ATC
0-L D01AA01 nystatin WHO ATC
0-L D01AA02 natamycin WHO ATC
0-L D01AA03 hachimycin WHO ATC
0-L D01AA04 pecilocin WHO ATC
0-L D01AA06 mepartricin WHO ATC
0-L D01AA07 pyrrolnitrin WHO ATC
0-L D01AA08 griseofulvin WHO ATC
0-L D01AA20 combinations WHO ATC
0-L D01AC Imidazole and triazole derivatives WHO ATC
0-L D01AC01 clotrimazole WHO ATC
0-L D01AC02 miconazole WHO ATC
0-L D01AC03 econazole WHO ATC
0-L D01AC04 chlormidazole WHO ATC
0-L D01AC05 isoconazole WHO ATC
0-L D01AC06 tiabendazole WHO ATC
0-L D01AC07 tioconazole WHO ATC
0-L D01AC08 ketoconazole WHO ATC
0-L D01AC09 sulconazole WHO ATC
0-L D01AC10 bifonazole WHO ATC
0-L D01AC11 oxiconazole WHO ATC
0-L D01AC12 fenticonazole WHO ATC
0-L D01AC13 omoconazole WHO ATC
0-L D01AC14 sertaconazole WHO ATC
0-L D01AC15 fluconazole WHO ATC
0-L D01AC16 flutrimazole WHO ATC
0-L D01AC20 combinations WHO ATC
0-L D01AC52 miconazole, combinations WHO ATC
0-L D01AC60 bifonazole, combinations WHO ATC
0-L D01AE Other antifungals for topical use WHO ATC
0-L D01AE01 bromochlorosalicylanilide WHO ATC
0-L D01AE02 methylrosaniline WHO ATC
0-L D01AE03 tribromometacresol WHO ATC
0-L D01AE04 undecylenic acid WHO ATC
0-L D01AE05 polynoxylin WHO ATC
0-L D01AE06 2-(4-chlorphenoxy)-ethanol WHO ATC
0-L D01AE07 chlorphenesin WHO ATC
0-L D01AE08 ticlatone WHO ATC
0-L D01AE09 sulbentine WHO ATC
0-L D01AE10 ethyl hydroxybenzoate WHO ATC
0-L D01AE11 haloprogin WHO ATC
0-L D01AE12 salicylic acid WHO ATC
0-L D01AE13 selenium sulfide WHO ATC
0-L D01AE14 ciclopirox WHO ATC
0-L D01AE15 terbinafine WHO ATC
0-L D01AE16 amorolfine WHO ATC
0-L D01AE17 dimazole WHO ATC
0-L D01AE18 tolnaftate WHO ATC
0-L D01AE19 tolciclate WHO ATC
0-L D01AE20 combinations WHO ATC
0-L D01AE21 flucytosine WHO ATC
0-L D01AE22 naftifine WHO ATC
0-L D01AE23 butenafine WHO ATC
0-L D01AE54 undecylenic acid, combinations WHO ATC
0-L D01B ANTIFUNGALS FOR SYSTEMIC USE WHO ATC
0-L D01BA Antifungals for systemic use WHO ATC
0-L D01BA01 griseofulvin WHO ATC
0-L D01BA02 terbinafine WHO ATC
0-L D02 EMOLLIENTS AND PROTECTIVES WHO ATC
0-L D02A EMOLLIENTS AND PROTECTIVES WHO ATC
0-L D02AA Silicone products WHO ATC
0-L D02AB Zinc products WHO ATC
0-L D02AC Soft paraffin and fat products WHO ATC
0-L D02AD Liquid plasters WHO ATC
0-L D02AE Carbamide products WHO ATC
0-L D02AE01 carbamide WHO ATC
0-L D02AE51 carbamide, combinations WHO ATC
0-L D02AF Salicylic acid preparations WHO ATC
0-L D02AX Other emollients and protectives WHO ATC
0-L D02B PROTECTIVES AGAINST UV-RADIATION WHO ATC
0-L D02BA Protectives against UV-radiation for topical use WHO ATC
0-L D02BA01 aminobenzoic acid WHO ATC
0-L D02BA02 octinoxate WHO ATC
0-L D02BB Protectives against UV-radiation for systemic use WHO ATC
0-L D02BB01 betacarotene WHO ATC
0-L D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS WHO ATC
0-L D03A CICATRIZANTS WHO ATC
0-L D03AA Cod-liver oil ointments WHO ATC
0-L D03AX Other cicatrizants WHO ATC
0-L D03AX01 cadexomer iodine WHO ATC
0-L D03AX02 dextranomer WHO ATC
0-L D03AX03 dexpanthenol WHO ATC
0-L D03AX04 calcium pantothenate WHO ATC
0-L D03AX05 hyaluronic acid WHO ATC
0-L D03AX06 becaplermin WHO ATC
0-L D03AX09 crilanomer WHO ATC
0-L D03AX10 enoxolone WHO ATC
0-L D03B ENZYMES WHO ATC
0-L D03BA Proteolytic enzymes WHO ATC
0-L D03BA01 trypsin WHO ATC
0-L D03BA02 collagenase WHO ATC
0-L D03BA52 collagenase, combinations WHO ATC
0-L D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. WHO ATC
0-L D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. WHO ATC
0-L D04AA Antihistamines for topical use WHO ATC
0-L D04AA01 thonzylamine WHO ATC
0-L D04AA02 mepyramine WHO ATC
0-L D04AA03 thenalidine WHO ATC
0-L D04AA04 tripelennamine WHO ATC
0-L D04AA09 chloropyramine WHO ATC
0-L D04AA10 promethazine WHO ATC
0-L D04AA12 tolpropamine WHO ATC
0-L D04AA13 dimetindene WHO ATC
0-L D04AA14 clemastine WHO ATC
0-L D04AA15 bamipine WHO ATC
0-L D04AA22 isothipendyl WHO ATC
0-L D04AA32 diphenhydramine WHO ATC
0-L D04AA33 diphenhydramine methylbromide WHO ATC
0-L D04AA34 chlorphenoxamine WHO ATC
0-L D04AB Anesthetics for topical use WHO ATC
0-L D04AB01 lidocaine WHO ATC
0-L D04AB02 cinchocaine WHO ATC
0-L D04AB03 oxybuprocaine WHO ATC
0-L D04AB04 benzocaine WHO ATC
0-L D04AB05 quinisocaine WHO ATC
0-L D04AB06 tetracaine WHO ATC
0-L D04AB07 pramocaine WHO ATC
0-L D04AX Other antipruritics WHO ATC
0-L D05 ANTIPSORIATICS WHO ATC
0-L D05A ANTIPSORIATICS FOR TOPICAL USE WHO ATC
0-L D05AA Tars WHO ATC
0-L D05AC Antracen derivatives WHO ATC
0-L D05AC01 dithranol WHO ATC
0-L D05AC51 dithranol, combinations WHO ATC
0-L D05AD Psoralens for topical use WHO ATC
0-L D05AD01 trioxysalen WHO ATC
0-L D05AD02 methoxsalen WHO ATC
0-L D05AX Other antipsoriatics for topical use WHO ATC
0-L D05AX01 fumaric acid WHO ATC
0-L D05AX02 calcipotriol WHO ATC
0-L D05AX03 calcitriol WHO ATC
0-L D05AX04 tacalcitol WHO ATC
0-L D05AX05 tazarotene WHO ATC
0-L D05AX52 calcipotriol, combinations WHO ATC
0-L D05B ANTIPSORIATICS FOR SYSTEMIC USE WHO ATC
0-L D05BA Psoralens for systemic use WHO ATC
0-L D05BA01 trioxysalen WHO ATC
0-L D05BA02 methoxsalen WHO ATC
0-L D05BA03 bergapten WHO ATC
0-L D05BB Retinoids for treatment of psoriasis WHO ATC
0-L D05BB01 etretinate WHO ATC
0-L D05BB02 acitretin WHO ATC
0-L D05BX Other antipsoriatics for systemic use WHO ATC
0-L D05BX51 fumaric acid derivatives, combinations WHO ATC
0-L D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE WHO ATC
0-L D06A ANTIBIOTICS FOR TOPICAL USE WHO ATC
0-L D06AA Tetracycline and derivatives WHO ATC
0-L D06AA01 demeclocycline WHO ATC
0-L D06AA02 chlortetracycline WHO ATC
0-L D06AA03 oxytetracycline WHO ATC
0-L D06AA04 tetracycline WHO ATC
0-L D06AX Other antibiotics for topical use WHO ATC
0-L D06AX01 fusidic acid WHO ATC
0-L D06AX02 chloramphenicol WHO ATC
0-L D06AX04 neomycin WHO ATC
0-L D06AX05 bacitracin WHO ATC
0-L D06AX07 gentamicin WHO ATC
0-L D06AX08 tyrothricin WHO ATC
0-L D06AX09 mupirocin WHO ATC
0-L D06AX10 virginiamycin WHO ATC
0-L D06AX11 rifaximin WHO ATC
0-L D06AX12 amikacin WHO ATC
0-L D06AX13 retapamulin WHO ATC
0-L D06B CHEMOTHERAPEUTICS FOR TOPICAL USE WHO ATC
0-L D06BA Sulfonamides WHO ATC
0-L D06BA01 silver sulfadiazine WHO ATC
0-L D06BA02 sulfathiazole WHO ATC
0-L D06BA03 mafenide WHO ATC
0-L D06BA04 sulfamethizole WHO ATC
0-L D06BA05 sulfanilamide WHO ATC
0-L D06BA06 sulfamerazine WHO ATC
0-L D06BA51 silver sulfadiazine, combinations WHO ATC
0-L D06BB Antivirals WHO ATC
0-L D06BB01 idoxuridine WHO ATC
0-L D06BB02 tromantadine WHO ATC
0-L D06BB03 aciclovir WHO ATC
0-L D06BB04 podophyllotoxin WHO ATC
0-L D06BB05 inosine WHO ATC
0-L D06BB06 penciclovir WHO ATC
0-L D06BB07 lysozyme WHO ATC
0-L D06BB08 ibacitabine WHO ATC
0-L D06BB09 edoxudine WHO ATC
0-L D06BB10 imiquimod WHO ATC
0-L D06BB11 docosanol WHO ATC
0-L D06BB53 aciclovir, combinations WHO ATC
0-L D06BX Other chemotherapeutics WHO ATC
0-L D06BX01 metronidazole WHO ATC
0-L D06C ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS WHO ATC
0-L D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS WHO ATC
0-L D07A CORTICOSTEROIDS, PLAIN WHO ATC
0-L D07AA Corticosteroids, weak (group I) WHO ATC
0-L D07AA01 methylprednisolone WHO ATC
0-L D07AA02 hydrocortisone WHO ATC
0-L D07AA03 prednisolone WHO ATC
0-L D07AB Corticosteroids, moderately potent (group II) WHO ATC
0-L D07AB01 clobetasone WHO ATC
0-L D07AB02 hydrocortisone butyrate WHO ATC
0-L D07AB03 flumetasone WHO ATC
0-L D07AB04 fluocortin WHO ATC
0-L D07AB05 fluperolone WHO ATC
0-L D07AB06 fluorometholone WHO ATC
0-L D07AB07 fluprednidene WHO ATC
0-L D07AB08 desonide WHO ATC
0-L D07AB09 triamcinolone WHO ATC
0-L D07AB10 alclometasone WHO ATC
0-L D07AB11 hydrocortisone buteprate WHO ATC
0-L D07AB19 dexamethasone WHO ATC
0-L D07AB21 clocortolone WHO ATC
0-L D07AB30 combinations of corticosteroids WHO ATC
0-L D07AC Corticosteroids, potent (group III) WHO ATC
0-L D07AC01 betamethasone WHO ATC
0-L D07AC02 fluclorolone WHO ATC
0-L D07AC03 desoximetasone WHO ATC
0-L D07AC04 fluocinolone acetonide WHO ATC
0-L D07AC05 fluocortolone WHO ATC
0-L D07AC06 diflucortolone WHO ATC
0-L D07AC07 fludroxycortide WHO ATC
0-L D07AC08 fluocinonide WHO ATC
0-L D07AC09 budesonide WHO ATC
0-L D07AC10 diflorasone WHO ATC
0-L D07AC11 amcinonide WHO ATC
0-L D07AC12 halometasone WHO ATC
0-L D07AC13 mometasone WHO ATC
0-L D07AC14 methylprednisolone aceponate WHO ATC
0-L D07AC15 beclometasone WHO ATC
0-L D07AC16 hydrocortisone aceponate WHO ATC
0-L D07AC17 fluticasone WHO ATC
0-L D07AC18 prednicarbate WHO ATC
0-L D07AC19 difluprednate WHO ATC
0-L D07AC21 ulobetasol WHO ATC
0-L D07AD Corticosteroids, very potent (group IV) WHO ATC
0-L D07AD01 clobetasol WHO ATC
0-L D07AD02 halcinonide WHO ATC
0-L D07B CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS WHO ATC
0-L D07BA Corticosteroids, weak, combinations with antiseptics WHO ATC
0-L D07BA01 prednisolone and antiseptics WHO ATC
0-L D07BA04 hydrocortisone and antiseptics WHO ATC
0-L D07BB Corticosteroids, moderately potent, combinations with antiseptics WHO ATC
0-L D07BB01 flumetasone and antiseptics WHO ATC
0-L D07BB02 desonide and antiseptics WHO ATC
0-L D07BB03 triamcinolone and antiseptics WHO ATC
0-L D07BB04 hydrocortisone butyrate and antiseptics WHO ATC
0-L D07BC Corticosteroids, potent, combinations with antiseptics WHO ATC
0-L D07BC01 betamethasone and antiseptics WHO ATC
0-L D07BC02 fluocinolone acetonide and antiseptics WHO ATC
0-L D07BC03 fluocortolone and antiseptics WHO ATC
0-L D07BC04 diflucortolone and antiseptics WHO ATC
0-L D07BD Corticosteroids, very potent, combinations with antiseptics WHO ATC
0-L D07C CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS WHO ATC
0-L D07CA Corticosteroids, weak, combinations with antibiotics WHO ATC
0-L D07CA01 hydrocortisone and antibiotics WHO ATC
0-L D07CA02 methylprednisolone and antibiotics WHO ATC
0-L D07CA03 prednisolone and antibiotics WHO ATC
0-L D07CB Corticosteroids, moderately potent, combinations with antibiotics WHO ATC
0-L D07CB01 triamcinolone and antibiotics WHO ATC
0-L D07CB02 fluprednidene and antibiotics WHO ATC
0-L D07CB03 fluorometholone and antibiotics WHO ATC
0-L D07CB04 dexamethasone and antibiotics WHO ATC
0-L D07CB05 flumetasone and antibiotics WHO ATC
0-L D07CC Corticosteroids, potent, combinations with antibiotics WHO ATC
0-L D07CC01 betamethasone and antibiotics WHO ATC
0-L D07CC02 fluocinolone acetonide and antibiotics WHO ATC
0-L D07CC03 fludroxycortide and antibiotics WHO ATC
0-L D07CC04 beclometasone and antibiotics WHO ATC
0-L D07CC05 fluocinonide and antibiotics WHO ATC
0-L D07CC06 fluocortolone and antibiotics WHO ATC
0-L D07CD Corticosteroids, very potent, combinations with antibiotics WHO ATC
0-L D07CD01 clobetasol and antibiotics WHO ATC
0-L D07X CORTICOSTEROIDS, OTHER COMBINATIONS WHO ATC
0-L D07XA Corticosteroids, weak, other combinations WHO ATC
0-L D07XA01 hydrocortisone WHO ATC
0-L D07XA02 prednisolone WHO ATC
0-L D07XB Corticosteroids, moderately potent, other combinations WHO ATC
0-L D07XB01 flumetasone WHO ATC
0-L D07XB02 triamcinolone WHO ATC
0-L D07XB03 fluprednidene WHO ATC
0-L D07XB04 fluorometholone WHO ATC
0-L D07XB05 dexamethasone WHO ATC
0-L D07XB30 combinations of corticosteroids WHO ATC
0-L D07XC Corticosteroids, potent, other combinations WHO ATC
0-L D07XC01 betamethasone WHO ATC
0-L D07XC02 desoximetasone WHO ATC
0-L D07XC03 mometasone WHO ATC
0-L D07XC04 diflucortolone WHO ATC
0-L D07XD Corticosteroids, very potent, other combinations WHO ATC
0-L D08 ANTISEPTICS AND DISINFECTANTS WHO ATC
0-L D08A ANTISEPTICS AND DISINFECTANTS WHO ATC
0-L D08AA Acridine derivatives WHO ATC
0-L D08AA01 ethacridine lactate WHO ATC
0-L D08AA02 aminoacridine WHO ATC
0-L D08AA03 euflavine WHO ATC
0-L D08AB Aluminium agents WHO ATC
0-L D08AC Biguanides and amidines WHO ATC
0-L D08AC01 dibrompropamidine WHO ATC
0-L D08AC02 chlorhexidine WHO ATC
0-L D08AC03 propamidine WHO ATC
0-L D08AC04 hexamidine WHO ATC
0-L D08AC05 polihexanide WHO ATC
0-L D08AC52 chlorhexidine, combinations WHO ATC
0-L D08AD Boric acid products WHO ATC
0-L D08AE Phenol and derivatives WHO ATC
0-L D08AE01 hexachlorophene WHO ATC
0-L D08AE02 policresulen WHO ATC
0-L D08AE03 phenol WHO ATC
0-L D08AE04 triclosan WHO ATC
0-L D08AE05 chloroxylenol WHO ATC
0-L D08AE06 biphenylol WHO ATC
0-L D08AF Nitrofuran derivatives WHO ATC
0-L D08AF01 nitrofural WHO ATC
0-L D08AG Iodine products WHO ATC
0-L D08AG01 iodine/octylphenoxypolyglycolether WHO ATC
0-L D08AG02 povidone-iodine WHO ATC
0-L D08AG03 iodine WHO ATC
0-L D08AG04 diiodohydroxypropane WHO ATC
0-L D08AH Quinoline derivatives WHO ATC
0-L D08AH01 dequalinium WHO ATC
0-L D08AH02 chlorquinaldol WHO ATC
0-L D08AH03 oxyquinoline WHO ATC
0-L D08AH30 clioquinol WHO ATC
0-L D08AJ Quaternary ammonium compounds WHO ATC
0-L D08AJ01 benzalkonium WHO ATC
0-L D08AJ02 cetrimonium WHO ATC
0-L D08AJ03 cetylpyridinium WHO ATC
0-L D08AJ04 cetrimide WHO ATC
0-L D08AJ05 benzoxonium chloride WHO ATC
0-L D08AJ06 didecyldimethylammonium chloride WHO ATC
0-L D08AJ08 benzethonium chloride WHO ATC
0-L D08AJ57 octenidine, combinations WHO ATC
0-L D08AJ58 benzethonium chloride, combinations WHO ATC
0-L D08AJ59 dodeclonium bromide, combinations WHO ATC
0-L D08AK Mercurial products WHO ATC
0-L D08AK01 mercuric amidochloride WHO ATC
0-L D08AK02 phenylmercuric borate WHO ATC
0-L D08AK03 mercuric chloride WHO ATC